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ABSTRACT 
VALERIE YURIEVNA SOLDATOW:  Evaluation of a Multiwell Perfused Bioreactor System 
for the Long-term Culture of Mouse Hepatocytes 
(Under the direction of Ivan Rusyn, MD. Ph.D.) 
 
Liver is the primary organ for xenobiotic metabolism and in vitro models that faithfully 
recapitulate its function are needed for medium/high-throughput toxicity studies. We 
evaluated a three-dimensional multiwell perfused bioreactor system as a model of murine 
liver.  System parameters (flow rate, seeding procedure and cell density, scaffold matrix, 
and media composition) were varied to identify optimal conditions for mouse hepatocytes.  
Biochemical assays (pyruvate, lactate, urea, albumin, and intracellular ATP) indicated that 
the three-dimensional system improves functionality of hepatocytes cultured for 3-5 days.  
We also tested hepatocyte’s basal and inducible metabolism using model toxicants 
acetaminophen and WY-14,643.  Finally, we cultured non-parenchymal cells with mouse 
hepatocytes to determine whether it may improve the functionality of cells.  This work 
demonstrates that the three-dimensional multiwell perfused bioreactor seeded with mouse 
hepatocytes is a useful model for short-term studies; however, improvements in the system 
are needed for it to become a promising sub-chronic model.  
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CHAPTER 1 
 
LITERATURE REVIEW 
 
Current Chemical Toxicity Testing 
 The gold standard toxicological approach for evaluating chemical toxicity involves 
complex in vivo studies which are both time consuming and costly.  Due to the pressures 
from animal activist groups, time constraints, cost reduction plans, the ever increasing 
number of chemicals and combinations of chemicals that need testing, and the need for 
high-throughput testing, establishing workable in vitro culture systems has become a priority 
for the toxicology community.  In addition, the predictivity of rodent in vivo testing of human 
toxic effects has become a matter of dispute in recent years, in part due to poor relevance of 
animal study results to heterogenous human populations (Holmes et al., 2010; National 
Research Council, 2007). The use of in vitro systems for toxicological testing has many 
advantages including the reduction in animal numbers, the reduced cost of animal 
maintenance and care, the reduced experimental variability, the reduced quantity of 
chemical needed for testing, and the decreased time needed and increase in ease of 
evaluating metabolites (LeCluyse, 1996; DelRaso, 1993).  In vitro systems also allow us to 
establish metabolic mechanisms of toxicity, measure enzyme kinetics, and establish dose-
response relationships (DelRaso, 1993).   
The U.S. National Toxicology Program (NTP) has established the Interagency 
Center for the Evaluation of Alternative Toxicological Methods (NICEATM) which works in 
conjunction with the Interagency Coordinating Committee on the Validation of Alternative 
Methods (ICCVAM) to establish and validate alternative methods to in vivo toxicological 
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testing.  The three main tenants for animal toxicity studies of these agencies are known as 
the three R’s:  refinement, reduction, and replacement.  The ultimate goal is “the validation 
and regulatory acceptance of test methods that are more predictive of adverse human and 
ecological effects than currently available methods, supporting improved protection of 
human health and the environment” (“About the National Toxicology Program”, 2011).  
The landmark report released by the National Research Council (NRC), “Toxicity 
Testing in the 21st Century: A Vision and a Strategy” (National Research Council, 2007), 
identified the challenges of modern toxicology and provided strategies for developing 
alternatives to in vivo research. The Council supports the movement towards the use of in 
vitro systems instead of in vivo toxicological studies and, as requested by the U.S. 
Environmental Protection Agency (EPA), has developed a long-term objective of decreasing 
the use of in vivo studies for toxicity testing and proposed an initial strategy towards 
achieving that goal.   In addition to the limitations mentioned above, the NRC acknowledges 
that in vivo study results cannot evaluate the much lower concentrations and mixtures of 
chemicals that humans are exposed to, lack information regarding modes and mechanisms 
of actions, and cannot account for human variability in responses and susceptibility 
(National Research Council, 2007).  The Council asserts that in vitro work can elucidate 
cellular-response networks and toxicity pathways, modes and mechanisms of action, allow 
for high-throughput studies, enhance dose-response relationships, evaluate many more 
concentrations than in vivo work, use concentrations relative to human exposure, provide 
information for generation of pharmaco-kinetic and -dynamic models, and lead to genome 
based investigations into perturbations of toxicity pathways.   
There are three important factors which hinder the ability to use animal models to 
predict human adverse effects and the National Research Council claims the use of in vitro 
models will allow us to address these factors.  First, in vivo studies typically use high doses 
of compounds which are orders of magnitude greater than those humans are exposed to.  
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Dose-response relationships are complex so extrapolation from these high doses to lower, 
human, exposure levels is difficult and results in many inaccuracies.  Second, in vivo studies 
examine the response of a standard laboratory animal to a toxicant.  This response may or 
may not occur in humans.  Even more important is that the human population is very 
heterogeneous and a single strain of animal cannot accurately predict the variability in 
responses seen in the human population.  Finally, in vivo exposures in toxicity testing are 
usually composed of a single compound.  While this allows for close examination of the 
results of that single compound, humans are constantly exposed to mixtures of compounds 
daily and the effects of these co-exposures need to be examined.  Conducting in vivo 
studies using mixtures of chemicals would be a monumental task due to the number of 
different chemicals and combinations of chemicals as well as the time it takes to complete 
each in vivo study. 
To overcome these limitations to in vivo studies, the National Research Council 
developed four criteria important to designing a new toxicity-testing paradigm: broaden the 
studies to include a greater number of chemicals and chemical mixtures as well as more end 
points and life-stages; decrease the time it takes to obtain results for risk assessment by 
reducing costs and length of tests and increasing efficiency and flexibility of said tests; 
reduce the number and suffering of animals involved in testing; and more closely examine 
mechanistic and dosimetry information to provide risk assessment organizations with a 
broader range of information.  The major components of the proposed strategy to establish 
this paradigm are chemical characterization, toxicity testing, and dose-response and 
extrapolation modeling.  The National Research Council has recognized the fact that this 
new toxicity-testing paradigm will require years of research and assay validation and may 
never fully eliminate the need for in vivo work; however the benefits of reducing the number 
of animal studies are well worth the effort.   
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One of the current major benefits of in vitro systems is their use in screening 
chemicals for prioritization purposes.  The EPA ToxCast™ project was established mainly 
for the purpose of prioritization of chemicals for further toxicological study by using high-
throughput in vitro assays to establish “toxicity signatures” of chemicals, identify toxicity 
pathways, and predict potential toxicity (Judson et al., 2009).  To do this, ToxCast™ uses a 
large number of cell-free or cell-based in vitro high-throughput assays.  The different assays 
measure perturbations in pathways that could lead to cellular toxicity and the results of 
ToxCast™ assays will be used to link particular genes to toxicity endpoints.  Researchers 
hope to use data produced by the high-throughput assays of ToxCast™ to supplement data 
from genomics, proteomics, and metabolomic studies to further elucidate toxicity pathways 
(Judson et al., 2010).  Unfortunately, the high-throughput screening results do not correlate 
well with in vivo toxicity and cannot account for biological processes related to toxicity such 
as exposure, biotransformation, toxicokinetics, and individual genetic diversity (Knudsen et 
al., 2011).  Thus, other in vitro methods must be examined to supplement these high-
throughput assays.  
  
Hepatocyte Cultures as In Vitro Systems 
The liver is the major source of metabolism and drug biotransformation, thus liver 
cells are a logical choice for toxicological and pharmacological testing.  Many different in 
vitro liver models have been employed over the years with the hopes that the effects after 
chemical treatment will be predictive of in vivo responses.  Tissue slices preserve the zonal 
characteristics of a hepatic lobule and contain functional bile canaliculi, however they 
decline rapidly in viability, are not homogenous in functionality, and functional activities 
cannot usually extend past 10 hours (Guillouzo, 1997; LeCluyse, 2001; Lerche-Legrand and 
Toutain, 2000).  Microsomes can be obtained from frozen liver tissue and allow for high 
throughput studies, but they lack any cytosolic enzymes and are limited in their use 
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(Houston and Carlile, 1997; Rodrigues and Wong, 1997).  Isolated perfused livers preserve 
liver structure and functionality of even bile canaliculi, however they are difficult to work with, 
lose functionality more quickly than tissue slices, and are limited in their throughput (Wolcoff 
et al., 1987; Brouwer and Thurman, 1996).  Immortalized hepatic cell lines lack phenotypic 
stability and normal gene expression (Yu et al., 2001; Wooster et al., 1993; MacDonald et 
al., 1994).  Suspensions of primary hepatocytes retain high levels of functionality but are 
also short-lived (Guillouzo et al., 1997; LeCluyse, 2001).   
Due to the limitations of the subcellular-, tissue- and organ-based in vitro models, as 
well as the need for higher throughput, cell lines, stem cells, and primary isolated cells are 
currently the most popular cellular models.  Immortalized cell lines, as mentioned, tend to be 
unable to maintain phenotypic characteristics and are genetically unstable (Yu et al., 2001; 
Wooster et al., 1993; MacDonald et al., 1994).  Few lines are able to express any liver-
specific functions and, of those, most are derived from tumors.  Common immortalized lines 
in use are Fa2N-4, HepG2, Hep3B, PLc/PRFs Huh7, HBG, and HepaRG (Guguen-Guillouzo 
and Guillouzo, 2010).  The HepG2 line was generated in the 1970s and expresses many 
liver-specific genes (Braiterman and Hubbard, 2009); however, the line varies between 
passages and as a result data can be difficult to interpret (Guguen-Guillouzo and Guillouzo, 
2010).  The more recently developed human hepatoma line, HepaRG, has retained the 
expression of many liver-specific functions as well as many cytochrome P450s, nuclear 
receptors, membrane transporters, and phase II enzymes (Aninat et al., 2006).  HepaRG 
cells have a stable karyotype, can differentiate into either hepatocyte or biliary lineages, 
have a high proliferative capacity, and have shown to produce data that is both reproducible 
and consistent (Marion et al., 2010; Guguen-Guillouzo and Guillouzo, 2010; Lubberstedt et 
al., 2011).  Unfortunately, the expression of liver-specific functions in HepaRG cells is still 
much lower than that of primary hepatocytes (Marion et al., 2010) and they came from a 
single donor, thereby reducing their predictive value for the human population.   
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Stem cells constitute a very small fraction of liver cells and evidence has shown that, 
when cultured, they can proliferate without losing phenotypic characteristics (Schmelzer et 
al., 2007).  It has also been demonstrated that in vitro hepatic stem cells, or even 
undifferentiated embryonic stem cells, can directly differentiate into hepatocyte-like cells 
(Navarro-Alvarez et al., 2010).  Unfortunately, these hepatocyte-like cells only express some 
of the many liver-specific features and express them in much lower levels than primary 
hepatocyte cultures and usually only under very specific culture conditions (Navarro-Alvarez 
et al., 2010; Snykers et al., 2006).  In addition, not much is understood of the differentiation 
process of these cells, the cell populations are quite variable, and their morphology and 
liver-like function is not stable for more than a few days (Navarro-Alvarex et al., 2010; 
Guguen-Guillouzo and Guillouzo, 2010).  For these reasons, stem cells are not yet a widely 
accepted option for toxicological and pharmacological studies. 
 Cultures of primary hepatocytes have been the gold standard for in vitro testing as 
they can maintain functional acitivites for 24-72 hours, can be used for enzyme induction 
and inhibition studies, allow for medium-throughput, and can easily examine interspecies 
and inter-individual differences in metabolism (LeCluyse, 2001; Sivaraman et al., 2005).  
Primary hepatocytes are used with the expectation that chemicals will affect an isolated cell 
in the same manner that they would affect the whole organ and will in this way be a 
predictive model (DelRaso, 1992). Traditional primary hepatocyte cell culture involves the 
method of plating cells on a rigid substratum in which they proceed to form a monolayer 
across the bottom of the culture plate well.  In this method, primary hepatocytes undergo 
changes in cell morphology, structure, polarity, gene expression, and liver-specific functions 
(LeCluyse, 1996; Nelson et al., 1982; Dunn et al., 1989), a process known as de-
differentiation.   Hepatocyte de-differentiation is an important limitation to this in vitro system.  
As the isolated cells have lost their normal microenvironmental structure, cell to cell 
interactions, and cell membrane structures, response to chemical exposures can be 
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different than those occurring in vivo. Lack of proper absorption, distribution, metabolism, 
and excretion (ADME) properties as a result of cellular disconnect from the circulatory and 
other organ systems also make assessment of chemical exposure results difficult with 
primary hepatocytes (DelRaso, 1993; LeCluyse, 2001).  Finally, one of the most problematic 
disadvantages of the use of primary hepatocytes for toxicological research is the drastic 
decrease in cell functionality over time.  Liver specific functions such as albumin production 
and cytochrome P450 expression decline quickly over the first 24-48 hours of culture as the 
cells begin to lose their differentiated status (LeCluyse, 1996; LeCluyse, 2001; Bader et al., 
1992; Nelson et al., 1982).  Extending culture longevity, both in terms of liver specific 
functions as well as basic cellular functionality, has been a great obstacle science has not 
yet been able to overcome.  
Several reasons for poor hepatocyte function in long-term culture have been 
suggested (see above).  Hence, many approaches to surmount this challenge have been 
proposed, including adjusting components of the culture medium, altering the extracellular 
matrix, changing the cell culture format (such as monolayer, spheroid, or 3D cultures), 
adding flow to the culture system, and culturing hepatocytes with other cell types, all of 
which are summarized in multiple reviews (Mitaka, 1998; LeCluyse, 2001; LeCluyse et al., 
1996; Meng, 2010; Coecke et al., 1999; Griffith and Swartz, 2006).  Although a number of 
investigators have found certain approaches to benefit hepatocyte culture in their own 
laboratories, difficulties in comparison of experimental results occur and continue to hinder 
the discovery of optimal culture conditions.  In addition, differences in species, strain, and 
sex of animal vary greatly across experiments.  Conditions of cell isolation are also variable 
as are the methods for cell purification, conditions of cell culture, and assay methods.  
Yields and viabilities of final cell preparations can differ depending on types of collagenase 
and perfusion methods used.  Species differences in optimal culture conditions abound as 
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well.  These factors must be taken into consideration when examining different culture 
systems and developing the proper procedures in one’s own laboratory. 
 
Three-dimensional Culture Systems 
Three-dimensional culture of hepatocytes is a burgeoning field of study as scientists 
attempt to recreate the complex cellular microenvironment of the liver in hopes of extending 
primary hepatocyte culture longevity and functionality.  3D cultures range in complexity from 
monolayer sandwich culture and spheroids to more advanced systems involving porous 
materials, packed-bed reactors, hollow fibers, and perfusion flow.   
 The microenvironment of the hepatocyte is very important and can be complex to 
mimic.  The importance of cell polarity has been stressed by many investigators and it has 
been suggested that without it hepatocytes will not function properly in culture (Dunn et al., 
1991).  Hepatocytes possess not only a single apical and basal surface, but have multiple 
apical surfaces (bile canalicular surfaces) and two basolateral surfaces (Dunn et al., 1991).  
For this reason, re-establishing cell polarity is not as easy as with other types of epithelial 
cells.  Different extracellular matrices (ECMs) have been extensively evaluated in 2D and 3D 
hepatocyte culture in an attempt to re-establish and subsequently maintain hepatocyte cell 
polarity.  Many configurations of matrices have been evaluated to determine optimal 
conditions for restoration of hepatocyte polarity.  The other main limitations of traditional 
two-dimensional culture, namely reduction of gene activity and expression of genes involved 
in phases I, II, and III of drug metabolism, mainly occur within the first 24-48 hours and 
these cultures have been shown to have a low sensitivity of drug hepatotoxicity detection 
(Meng, 2010).  The use of tree-dimensional liver cultures can overcome deficits of the 2D 
culture system by providing models with more complex local environments.   
Three-dimensional culture systems have evolved greatly within the last 10—20 
years; initially composed of a simple sandwich configuration where hepatocytes would be 
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placed between two layers of matrix (traditionally collagen or Matrigel®).  Collagen 
sandwiches increase and maintain albumin secretion, maintain polygonal morphology 
similar to that of in vivo cells, prevent loss of cell viability, increase basal enzyme activities, 
increase and maintain enzyme induction, and mimic in vivo biliary excretion rates (Bader et 
al., 1992; Dunn et al., 1989; LeCluyse et al., 2000; Mingoia et al., 2007; Liu et al., 1999).  
Some of these functions are retained for relatively long periods of 24 days to 7 weeks in rat 
hepatocytes.  Investigators attribute these positive effects to cell polarity which was induced 
by the ECM (Dunn et al., 1989).  Research has shown that sandwich culture prevents the 
formation of stress fibers in addition to increasing transferrin, fibrinogen, and bile salt 
secretion, and stabilizing urea secretion in rat hepatocytes over 42 days (Dunn et al., 1991).  
Mouse hepatocytes also respond well to the sandwich culture method.  Genes responsible 
for liver-specific functions lose expression over time (90 hours) while those involved in gross 
cellular organizations increase in activity. In general, phase I enzyme gene expression 
decreases over time but phase II enzymes stay stable and data indicate that P450 gene 
expression in sandwich cultured mouse hepatocytes is more stable than in rat hepatocytes 
(Mathijs et al., 2009).  The loss of phenotype that occurs despite culturing hepatocytes in a 
sandwich system has been suggested as a cause of the decline of metabolic enzyme 
activity in these cultures and that application of the sandwich culture model is best used for 
hepatobiliary mechanistic studies (Meng, 2010).  Thus, other strategies to extend culture 
period and retain hepatocyte function have been employed. 
Spheroid culture was the next 3D model evaluated for hepatocyte culture, with the 
assumption that cellular aggregates better mimic liver tissue characteristics.  Working with 
self-forming hepatocyte spheroids was initially a complex undertaking involving an initial 
culture period for spheroid formation prior to the hepatocytes being available for any 
toxicological or pharmacological experimentation.  In 1996, Wu and colleagues optimized a 
protocol for quick production of rat hepatocyte spheroids through use of spinner flasks (Wu 
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et al., 1996).  They observed rat hepatocyte spheroid physiology and found that oxygen 
supply was critical in the proper formation of spheroids and that these cells maintained a 
more differentiated state than those of monolayer culture.  Cyp1a2 and Cyp1a1 expression 
levels dropped rapidly in normal 2D monolayer culture in mouse hepatocytes while in 3D 
spheroids the levels stayed high over 5 days (Nemoto and Sakurai, 1992; Nemoto and 
Sakurai, 1993) which indicates that spheroid culture is preferred over monolayers for studies 
evaluating levels of gene expression.  Spheroid culture of mouse hepatocytes can also 
maintain Cyp2b9 and Cyp2b10 for a number of days at levels equal to in vivo (Nemoto et 
al., 1995).  Du et al. (2006) were able to develop a 3D monolayer culture configuration by 
conjugating cell adhesion peptides Arg-Gly-Asp (RGD) with galactose ligand and 
polyethylene terephthalate.  They determined that the rat hepatocyte spheroid configuration 
was ideal; by using this new culture system cells would anchor well to the substrata and 
have a limited ability to spread while still keeping the functional characteristics of spheroids.  
Liver specific functions of cells on the new substratum, such as albumin secretion and urea 
synthesis, were similar to that of spheroids.  These cells also exhibited greater sensitivity to 
acetaminophen-induced hepatotoxicity than those cultured on traditional 2D collagen.  
However, due to oxygen and nutrient diffusion difficulties, spheroid culture is limited in its 
ability to be used for bioartificial liver models or long-term culture, thus more 3D models 
were investigated. 
Gelled materials have been devised to combine the complexity of a Matrigel®-type 
ECM with spheroid formation.  The idea of culturing hepatocytes encapsulated within gel 
was originally developed for use in a bioartificial liver where semi-permeable hollow fiber 
cartridges were used as a scaffold for hepatocyte attachment (Meng, 2010).  Miccheli and 
associates entrapped rat hepatocytes in alginate beads and placed them in a bioreactor 
system with a continuous flow of medium (Miccheli et al., 2000).  In this system energy 
metabolism, viability, and redox state was stable within 3 hours and the proper shape, 
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microvilli, tight junctions, and bile canaliculi were reformed within 8 hours.  The authors 
confirmed previous demonstrations that adequate supply of oxygen and substrates is critical 
for proper cellular reorganization in these systems.  They observed increased 
glycerophosphorylethanolamine levels in the static cultures indicating problems with 
membrane phospholipid metabolism regulation contrasting low levels in the bioreactor 
system.  Gels of agarose have been employed to sustain viability of mouse hepatocyte 
cultures for 21 days.  Within these gels, hepatocytes typically form aggregates and excrete 
significantly higher amounts of albumin than their 2D counterparts (Ise, 1999).  Shen et al. 
(2006) demonstrated that gel entrapped hepatocytes expressed higher levels of liver-
specific functions and phase I metabolism, maintained higher intracellular ATP levels and 
mitochondrial membrane potential, and accumulated less lipids within the cytoplasm than 
those cultured in traditional 2D monolayer.  In addition, measurements of phase I metabolic 
enzymes were similar to levels found in vivo.  Furthermore, gel entrapped cultures have 
been able to accurately reflect hepatotoxicity in over twenty reference compounds (Lu et al., 
2008).  Some of these gel culture systems limit mass transfer of oxygen and nutrients while 
others require large amounts of reagents, thus models using a type of scaffolding to provide 
structural support and semi-permeable hollow fibers were developed.  Some of these fiber 
systems incorporated gel entrapment while others did not.  Investigators were able to obtain 
rat hepatocyte cultures with increased functionality through use of scaffolding composed of 
polyvinyl formal resin and nanofibers (Miyoshi et al., 1998; Chu et al., 2009).  The 
scaffolding increased cell adhesion, even in high density, lower LDH release, and 
maintained biochemical functions such as albumin secretion, urea synthesis, and glycogen 
synthesis.  Stabilization of albumin and urea levels after an initial decline was noted in a 
functional 20-day rat culture (Miyoshi et al., 1998).  Shen and colleagues examined a simple 
micro-hollow fiber reactor system for rat hepatocytes and determined that functionality (in 
terms of urea synthesis and albumin secretion) was increased in this system when 
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compared to simple monolayer culture (Shen et al., 2007).  The system increased metabolic 
capabilities as well, as indicated by greater sensitivity to chemical insult than seen in cells in 
monolayer culture.   
Incorporating fluid flow to three-dimensional culture systems was an important 
addition to tissue engineering.  Packed-bed, hollow fiber, or other type of “reactors” integrate 
micro-circulation of medium to recreate the fluid flow within the liver.  Addition of flow to 3D 
cultures is important in combating the issues of poor oxygen and nutrient diffusion through 
spheroids and aggregates of cells. Systems incorporating shear flow have shown to 
promote round cell aggregates that are more similar to in vivo morphology and increase and 
maintain liver-specific functions (Kan et al., 2004).  Flow has shown to increase and 
maintain a higher level of urea synthesis (Taguchi et al., 1996) and to increase albumin, 
lactate, and glucose secretion (Kim et al., 1998).  Physiologic oxygen gradients can be 
established in these microfluidic systems and this can assist in elucidating the physiological 
mechanisms involved in toxicity (Allen et al., 2005).   Furthermore, the organotypic 
physiological geometries and flow properties in these systems allow for the study of drug-
drug and cell-cell interactions (Chao et al., 2009). 
Although these methods of three-dimensional hepatocyte culture show improvement 
over traditional two-dimensional cultures they are still insufficient for long-term culture or use 
in clinical therapies (such as bioartificial livers) due to the continued loss of metabolic gene 
expression after cell isolation.  Thus, it is no surprise that more complex 3D systems are 
being engineered. The 3-D culture systems under development use existing knowledge 
regarding the important cellular environment dynamics between extracellular matrix, micro-
circulation, and cell type and density, to form a fully functional liver culture model that can be 
used for toxicological and pharmacological studies or even modified into a bio-artificial liver 
for clinical use.  A few systems will be briefly discussed here. 
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HµREL® Biochip.  Chao et al. (2009) published an evaluation of a novel microfluidic 
device, a HµREL® biochip (an earlier model of this system was previously described by Sin 
et al., 2004).  Four biochips are enclosed in a polycarbonate housing connected, by tubing 
lines, to a fluid reservoir and peristaltic pump.  Each biochip has one or more separate 
compartments in which different cells can be housed.  The compartments are microfluidically 
connected, in a linear path, to allow for interaction between the cell types.  A new design 
allows for separate microfluidic experiments to be run in parallel on a larger set of housing 
plates.  Evaluation of the system using primary human hepatocytes indicated the system 
preserved cell viability and metabolic competency was at least as high as, and sometimes 
higher than, the traditional static culture conditions (Chao et al., 2009; Novik et al., 2010).  
The microscale system allows for microscopic imaging, oxygen sensing, physiologically 
realistic ratios of chamber sizes and liquid residence times in each compartment, 
physiological hydrodynamic shear stress, physiological liquid to cell ratios, and requires less 
media and cells.  The model is severely limited, however, in that sample removal is difficult 
without disturbing the system dynamics, recirculation of the media involves a complex set of 
tubing lines and reservoirs, and cells on chips form monolayers and not physiological tissue 
constructs. 
Hollow-Fiber Reactor.  A hollow-fiber based bioreactor was used by Schmelzer et al. 
(2009) for the regeneration and culture of human hepatocytes.  Cells are seeded into the 
extracapillary space and are surrounded by three independent capillary membrane systems.  
The capillary systems are composed of porous polyethersulphone and hydrophobic 
multilaminate hollow fiber membranes which allow for gas exchange.  The capillary layers 
are interwoven around the extracapillary space and two of the capillary systems are 
perfused in a counter-current flow with either culture medium or plasma while the third 
allows for decentralized oxygenation and supply of nutrients.  The bioreactor functions 
through use of a perfusion device that uses pressure-regulated pumps to control the 
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medium flow.  A gas mixing unit is also used to provide the system with, and control the 
rates of, air, O2, and CO2.  Human hepatocyte functionality was stable for up to four weeks 
in this bioreactor system.  Although this bioreactor system allowed for a microenvironment 
more similar to in vivo conditions, the system was large and required high numbers of cells 
and large amounts of reagents.  A microscale prototype version of this bioreactor was then 
developed (Schmelzer et al., 2010).  In this smaller model, the bioreactor is comprised of 
four cell chambers each of which contains four compartments.  The first compartment 
houses the cells, two contain culture medium, and the last provides the oxygen supply.  All 
compartments are connected to provide the cells with a physiologically-based environment.  
This micro-bioreactor has thus far been used for human fetal liver cell culture and has 
sustained cell viability and differentiation.  The prototype allows for small numbers of cells 
and limited reagent use, microscopic evaluation of the cells, and monitoring of oxygen 
concentrations.  In addition, the counter-directional perfusion method is unique in providing 
a more physiologically similar flow.  Limitations to this system include a lack of physiologic 
gradients normally seen in liver tissue, the complication of numerous tubing lines, and 
limited throughput as only four different culture conditions can be evaluated on a single 
system. 
Single- and Multi-Well Perfused Bioreactor.  Sivaraman et al. (2005) used a 3D 
bioreactor system to evaluate the functionality of rat hepatocyte spheroids.  They had 
hypothesized that a system that included heterotypic cell interactions, fluid flow stresses, 
and microarchitecture similar to that in vivo would provide the incentive for cells to function 
as they do in vivo.  This system housed spheroids of rat hepatocytes attached within the 
many channels of a silicon scaffold.  Perfusion of the medium was directed both over the top 
of the channels as well as through the tissue in the channels.  A high-resistance filter 
controlled the perfusion through the channels so flow was uniform through all channels of 
the scaffold.  Flow was initially in a downward direction to trap the cells in the channels and 
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later, after the cells had adhered to the channel walls, the flow was reversed.  Spheroids 
seeded in the bioreactor system had an increased and sustained functionality when 
compared to spheroids in both static culture and single cells seeded into the bioreactor 
system.  Both urea synthesis and albumin excretion were increased and more stable with 
the spheroid bioreactors.  This bioreactor system was scaled up easily to incorporate more 
channels (and thus, more cells) as well as up to 6 different reactors controlled by the same 
unit.  The scaffolds promote tissue morphogenesis and allow for microscopic examination 
via light or two-photon microscopes.  This cell culture system still lacks high-throughput 
capabilities, does not accommodate large numbers of cells, and needs to be examined with 
hepatocytes from other species.   
Although much progress has been made over the traditional two-dimensional static 
culture system, we are still lacking a model in which all levels of liver-specific function can be 
maintained for long periods of time.  Furthermore, many of the models have yet to establish 
whether the systems can function with hepatocytes from more than a single species. 
 
Co-culture Systems 
In the body, cells function by way of complex interactions and signals from other 
cells.  For this reason, we can assume that cultures of solely hepatocytes may not properly 
represent in vivo functionality especially when examining drug related hepatotoxicity.  
Hepatocyte co-cultures are usually comprised of hepatocytes with one other cell type, often 
other liver cells (Ries et al., 2000; Higashiyama et al., 2004; Krause et al., 2009; Tukov et 
al., 2006), non-liver epi- or endothelial cells (Gebhardt et al., 1998; Talamini et al., 1998), 
fibroblasts or cell lines (Evenou et al., 2011; Bhatia et al., 1998; Kang et al., 2004).  Co-
cultures have also been prepared using hepatocytes and more than one additional cell type, 
such as hepatocyte-non-parenchymal cell (NPC) cultures.  In these cultures the hepatocytes 
are cultured with the other liver cells:  Kupffer cells (resident macrophages), sinusoidal 
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endothelial cells, and stellate cells (stromal cells).  Co-culturing hepatocytes with other cell 
types have been shown to be one of the most successful techniques for maintaining 
hepatocyte function in in vitro models (Guguen-Guillouzo et al., 1983; Begue et al., 1984; 
Kaihara et al., 2000; Gueguen-Guillouzo and Guillouzo, 2010). 
Griffith and colleagues demonstrated that hepatocytes seeded with bovine aortal 
endothelial cells could form three dimensional structures in a polymer scaffolding system 
with flow (Griffith et al., 1997).  Within these structures hepatocytes bound to the substrata 
and the endothelial cells flattened and “covered” the hepatocytes.  Other investigators have 
found increases in albumin secretion and urea synthesis in rat hepatocytes when cultured 
with mouse embryonic fibroblasts, 3T3-J2, or NIG-3T3 cells.  Other benefits included 
retention of hepatic polygonal morphology, visible bile canaliculi, and distinct nuclei (Khetani 
et al., 2004). Mouse hepatocytes demonstrated better maintenance of albumin secretion 
and urea synthesis over a 7 day culture period when allowed to form 3D aggregates with 
mouse liver fibroblasts.  The importance of the physical interactions between the two cell 
types was evident. Increased liver-specific functionality developed when the cells were in 
contact in the same culture rather than on different substrata (Jiman and Meifu, 2000).  
Results from a study culturing micropatterned hepatocytes (produced by seeding on a 
stencil and then removing the stencil) on a 3T3-J2 fibroblast feeder layer indicate that this 
type of co-culture can lead to increased and maintained albumin and urea production as well 
as retained hepatocyte morphology (Khetani and Bhatia, 2008).  The importance of the 
heterotypic interface between the hepatocytes and fibroblasts further exemplifies the 
importance of cell-cell contacts in hepatocyte culture (Cho et al., 2010).   
Not only can cell-cell contacts with fibroblasts, cell lines, and epi- and endothelial 
cells affect hepatocytes in culture, but the soluble factors excreted by other cell types have 
been shown to be extremely important as well.  Cultures of rat hepatocytes in medium 
conditioned by cardiac endothelial cells functioned similarly to hepatocytes cultured under a 
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layer of endothelial cells and gel (Jindal et al., 2009).  Hepatocytes were shown to modulate 
endothelial activation states as well (Jindal et al., 2011).  Morin et al. (1988) observed 
similar increases in albumin secretion in culture systems in which the endothelial cells and 
hepatocytes were not in contact as cultures in which the cells were in contact.  These non-
contact co-cultures have had varied success and limited reproducibility between 
laboratories, however, thus cell-cell contacts continue to be one of the most important 
features of co-cultures (Coecke et al., 1999; Bhatia et al., 1999). 
The addition of liver non-parenchymal cells to cultures of hepatocytes is required to 
reconstruct an organotypic environment that can approximate in vivo conditions.  Many 
publications report on the benefit of non-parenchymal cells on hepatocyte function.  Ries et 
al. (2000) described a hepatocyte-NPC co-culture model in which hepatocytes were seeded 
on top of the NPC layer (containing Kupffer, stellate, and sinusoidal endothelial cells).  In 
their cultures, sinusoidal endothelial cells survived and maintained their fenestrae for 6 days.  
Other cell types remained viable for up to 14 days.  They were able to demonstrate that not 
only did the presence of the NPCs maintain hepatocyte differentiation, but the hepatocytes 
contributed to survival of the NP cells.  Experiments of human hepatocytes with non-
parenchymal cells, in a system with flow, have shown to have greater drug metabolic 
capabilities and better maintenance of that activity than cultures composed solely of 
hepatocytes (Novik et al., 2010).  Other cultures of hepatocytes with non-parenchymal cells 
found that stimulation of hepatocyte DNA replication after treatment with known 
hepatotoxicant WY-14,643 was enhanced compared to cultures of hepatocytes alone, 
indicating that the co-cultures result in more in vivo-like responses to treatment (Karam and 
Ghanayem, 1997).  Tukov et al. (2006) examined the effects of Kupffer cells cultured in 
contact with rat hepatocytes.  They found that by adding Kupffer cells to the cultures they 
could mimic in vivo drug-inflammation interactions thus providing a model which could be 
useful in predicting such interactions before in vivo studies were necessary.   Co-cultures of 
18 
 
rat primary hepatocytes and stellate cells on a poly (DL-lactic acid) surface quickly formed 
spheroidal aggregates and maintained liver-specific functions for over 2 months.  
Cytochrome P450 enzyme induction was maintained for almost the whole culture period 
(Riccalton-Banks et al., 2003).  Stellate cells have also been shown to promote cell 
proliferation when in contact with hepatocytes and maintain hepatocyte differentiation when 
cultured without direct contact (Higashiyama et al., 2004).   
It has been suggested that any bio-artificial device composed of primary cells will 
require non-parenchymal cells in order to maintain tissue-specific functions (Soto-Gutierrez 
et al., 2010).  Bioartificial liver devices are being developed to not only assist in the 
treatment of liver failure but also for use in drug metabolism and toxicological studies 
(Sharma et al., 2011). Whether or not a bioartificial liver or other type of three-dimensional 
model would best predict in vivo responses to chemical treatment remains to be seen; 
however the identification of micro-environment requirements, such as the presence of non-
parenchymal cells, is critical to the development and application of these systems. 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
 
OBJECTIVES 
 
Inter-individual Variation in In Vitro Systems 
The National Research Council Committee on Toxicity Testing and Assessment of 
Environmental Agents recognizes that in vitro tests need to take a more prominent position 
in the toxicity-testing paradigm.  Although they developed a strategy containing different 
tiers of evaluation which include extensive in vitro work, their proposal is based on the use 
of human cell lines.  The committee does admit, however, there are many limitations to the 
use of such cell lines (NRC, 2007).  As mentioned previously, cell lines lack phenotypic 
characteristics of cells in vivo and expression of liver-specific functions is limited.  One of the 
most important limiting factors of cell line use is the lack of inter-individual variability found in 
these lines.  Primary cells, then, become a more preferred method of in vitro evaluation. 
Human hepatocyte cultures are useful in toxicological and pharmacological studies 
as well as risk assessment as they eliminate species differences in response to chemicals, 
however initial levels of metabolic capacity as well as induction ability can vary greatly 
between human donors (Novik et al., 2010; LeCluyse, 2001).  To reduce this inter-individual 
variability and accurately predict the human population scale of responses, reproduction of 
the experiment using multiple donors or combining cells from donors would be required 
(Novik et al., 2010). An animal model which could account for the range of human variability 
would be a great resource in eliminating this predicament.  
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Previous Studies Using Multi-Strain Mouse Models of Hepatocytes 
Our laboratory has previously utilized an in vivo inbred mouse diversity panel to 
model the variability in drug responses seen in the human population (Harrill et al., 2009).  
In that model, 36 inbred mouse strains were used to demonstrate the variability seen in 
response to administration of acetaminophen and identify specific genes involved in these 
different responses.  When the results from experimentation with mice were validated by a 
human cohort, investigators determined the mouse strain panel could be used in 
prescreening studies to identify individuals susceptible to drug or environmental pollutant 
toxicities (Harrill et al., 2009b; Bradford et al., 2011).  
Subsequently, our laboratory investigated the possibility that these strain differences 
could be modeled in vitro.  The functionality of hepatocytes from 15 inbred mouse strains 
was initially examined and significant differences in gene expression levels were found.  
Experiments were then conducted on three of the 15 strains to determine if the model would 
accurately reflect strain differences in response to treatment with four reference compounds.  
Differences were noted, although the findings did not correlate well to the in vivo study due 
to changes in the ranking of sensitivity and resistance to acetaminophen treatment (Martinez 
et al., 2010).  Nevertheless, the results indicate that a panel of inbred mice can be a 
valuable tool in examining inter-individual variation in toxicity responses.   
 
Hypothesis and Goals 
Powers et al. (2002) and Sivaraman et al. (2005) demonstrated that rat hepatocyte 
cultures, as well as co-cultures with endothelial cells, could present phenotype, albumin and 
urea levels, and gene expression more similar to in vivo tissue than either 2D or spheroid 
cultures when placed in a 3D bioreactor that provided the cells with continuous perfusion of 
medium.  Their work led to development of a 3D multiwell perfused bioreactor system 
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designed for increased ease of use as well as increased throughput (Domansky et al., 
2010).  This system conferred the same types of benefit to rat cultures and co-cultures as 
the previous flow systems.  Therefore, our hypothesis was that it could easily be applied for 
use with mouse hepatocytes.  The successful long-term culture of mouse hepatocytes in this 
system would afford the opportunity to apply our genetically diverse mouse panel model to a 
more complex, in vivo-like environment for more accurate in vitro responses to chemical 
treatment.   
  Our goals were to 1) optimize the bioreactor system for mouse hepatocyte culture, 
2) use the system to evaluate responses to chemical treatment in a mouse diversity panel, 
and 3) establish co-cultures of hepatocytes and non-parenchymal liver cells to further 
elucidate the contribution of the other cell types in toxicity responses. 
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CHAPTER 3 
 
CHARACTERIZATION OF MOUSE HEPATOCYTES IN THE BIOREACTOR SYSTEM 
 
PART I:  Materials and Methods 
 
Reagents and Solutions 
Type IV and Type IA collagenase, Percoll, dexamethasone, fetal bovine serum 
(FBS), Williams’ Medium E (WEM),  pyruvic acid, lactate dehydrogenase, triethanolomine, 
β-Nicotinamide adenine dinucleotide hydrate and reduced dipotassium salt (NAD and 
NADH), hydrazine monohydrate, trypan, Optiprep™, adenosine triphosphate (ATP), D-
glucose, fructose, and ethylene glycol tetraacetic acid (EGTA) were purchased from Sigma 
Aldrich (St. Louis, MO, USA).  Antibiotic-Antimycotic solution, Insulin-Transferrin-Selenium 
(ITS) solution, sodium pyruvate, GlutaMAX™, TRIzol®, Hanks’ Balanced Salt Solution 
(HBSS) (without calcium and magnesium), HBSS (containing calcium and magnesium), 
Dulbecco’s Phosphate-Buffered Saline (DPBS), Dulbecco’s Modified Eagle Medium 
(DMEM), MEM non-essential amino acid solution, and rat anti-Glial Fibrillary Acidic Protein 
(GFAP) and anti-mouse platelet-endothelial cell adhesion Molecule 1 (PECAM-1 or CD-31) 
fluorochrome conjugated antibodies were purchased from Gibco/Invitrogen (Carlsbad, CA, 
USA).  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), PureCol Collagen, 
Biocoat tissue culture plates, and glycine, were purchased from Fisher Scientific (Waltham, 
MA, USA).  Matrigel™ was purchased from BD (Franklin Lakes, NJ, USA).  Anit-mouse 
F4/80 antigen PE fluorochrome conjugated antibody was purchased from eBioscience (San 
Diego, CA, USA). 
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Animals and Preparation for Surgery 
Hepatocytes were isolated from male C57Bl/6J and CD-1 mice aged 4-17 weeks and 
non-parenchymal cells were isolated from male C57Bl/6J and CD-1 mice aged 6-20 weeks 
(purchased from Jackson Laboratories, Bar Harbor, ME and Charles River, Wilmington).  
Mice were housed by strain, no more than five per cage, in polycarbonate microisolator or 
Tecniplast ventilated cages.  Animals were kept on an alternating 12-hour light and dark 
cycle and food (Purina Prolab® RMH3000, Purina Mills, Inc., Richmond, IN, USA) and water 
were provided ad libetum.  All procedures were approved by the Institutional Animal Care 
and Use Committee of the University of North Carolina, Chapel Hill, NC.  Prior to surgery, 
mice were anesthetized by an injection of Nembutal® (100mg/kg, sodium pentobarbital, 
Lundbeck Inc., Deerfield, IL).  
 
Isolation and Culture of Hepatocytes 
Upon reaching a surgical plane of anesthesia, mice were placed in a supine position 
and the liver was perfused in situ in a two-step collagenase perfusion method modified from 
Seglen (1976) and Klaunig et al. (1981).  A cannula was inserted through the right atrium of 
the heart into the superior vena cava, the portal vein was cut, and the liver was perfused 
with HBSS, containing 0.5mM EGTA but without calcium and magnesium, for 4 minutes 
followed by HBSS, containing calcium, magnesium, and 0.1-0.4mg/mL collagenase, for 7-12 
minutes.  Upon visual confirmation of digestion, the livers were flushed with a supplemented 
WEM buffer (see Appendix A for formulation; HEPES, GlutaMAX™, dexamethasone, ITS, 
Antibiotic-Antimycotic) containing 10% FBS.  Livers were then excised and placed into same 
medium and gently dissociated by removing the capsule and gently shaking the liver.  The 
cell suspension was filtered through a 100µm nylon cell strainer (BD Falcon, Fisher 
Scientific) and yield and viability were analyzed on a hemocytometer by trypan blue 
exclusion.  Cell suspensions of greater than 80% viability and good cell quality were taken 
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through the remainder of the isolation procedure.  Following filtering, cells were purified by 
three centrifugation steps; 50 x g for 3 minutes, 68 x g for 4 minutes, and 50 x g for 3 
minutes.  At each step the supernatant was removed and the pellet resuspended in the 
supplemented WEM.  For the second spin a 50% (v/v) isotonic Percoll gradient was used to 
isolate only the viable hepatocytes from the suspension.  Upon completion of the 
purification, the trypan blue exclusion test was once again used to determine the final yield, 
viability, and cell quality of the preparation.  Only cell preparations of more than 90% and 
good cell quality (as determined through visual examination of cell membrane integrity, 
extent of membrane blebbing and cytoplasm vacuolization, amount of cell clumps, and 
amount of debris) were used for experiments.  Cell suspensions were diluted to desired 
seeding densities (unless otherwise noted, 150,000 cells per well for 24 well plates and 
600,000 cells per bioreactor scaffold), seeded onto appropriate substrata and subsequently 
placed into an incubator set at 37ºC and 5% CO2.  Cells were allowed to attach for 4 hours 
at which point the seeding medium was removed and replaced with feeding medium (same 
as seeding medium minus the FBS).  Culture medium was removed and replaced with fresh 
medium daily.  
 
Isolation of Non-parenchymal Cells 
Upon reaching a surgical plane of anesthesia, mice were placed in a supine position, 
blood was flushed from the liver, and cells were isolated using a slight modification of the 
methods reported by DeLeve (1994).  Briefly, a 27g butterfly needle was inserted into the 
portal vein, the inferior vena cava was cut, and the liver was perfused in situ for 45 seconds 
with Gey’s buffered saline (GBS; see Appendix B for formulation and vendor information).  
Upon completion, the liver was removed and rinsed three times with GBS buffer before 
being placed into a petri dish and dissociated using a scissors and forceps.  The liver pieces 
were then placed into a 100mL beaker with collagenase solution (Sigma Type IA 
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collagenase).  The beaker was placed into a 37ºC waterbath and swirled every 4-5 minutes 
for 30 minutes.  The liver slurry was filtered through a 297µm filter (Spectra/Mesh, Spectrum 
Labs, Rancho Dominquez, CA) and placed into a 50mL conical tube with GBS.  Following 
filtering, the cells were purified by three 4ºC centrifugations steps; 400 x g for 15 minutes, 
1400 x g for 15 minutes, and 400 x g for 15 minutes.  For the first and last spin the 
supernatant was removed and the pellet resuspended in GBS buffer.  For the second spin 
the cell suspension was mixed with Optiprep™ to form a 17% final Optiprep™ solution with 
1mL of GBS layered on top.  Non-parenchymal cells were collected from the interface of the 
GBS and Optiprep™ solution.  Upon completion of the purification cells were evaluated by 
trypan blue exclusion and a cell count was taken.  All NPC preparations had a final viability 
of no less than 98%.  Cell suspensions were diluted to desired seeding densities in WEM 
with 10% FBS and seeded onto appropriate substrata containing recently seeded 
hepatocytes, and subsequently placed into an incubator set at 37ºC and 5% CO2.  Medium 
was changed at 4 hours post hepatocyte seeding (usually approximately 2 hours post NPC 
seeding).  
 
Evaluation of Non-parenchymal Cell Populations 
In most cases, an aliquot of cells was removed prior to suspension dilution and this 
aliquot was centrifuged for 14,000 rpm for 4 minutes, fixed with 2% PFA, and stored in 0.1% 
Tween at 4ºC.  Within 7 days, these cells were removed from storage, centrifuged for 4,000 
rpm for 4 minutes, incubated for 45-60 minutes with fluorochrome labeled antibodies, rinsed 
by centrifugation two to three more times (4,000 rpm for 4 minutes), filtered, and evaluated 
by flow cytometry.  Cells were analyzed on a Beckman Coulter (Dako) CyAn ADP (Beckman 
Coulter, Brea, CA).  Data were analyzed using Cyflogic software (CyFLo Ltd, Turku 
Finaland).  Briefly, forward and side scatter characteristics were used to exclude cell debris 
and hepatocytes from the analysis.  An unstained population was used to set a gate and all 
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events outside that gate (along a single axis) were considered positive for the defined 
population.      
 
Evaluation of Cellular Morphology 
Cells in 2D culture were examined and photographed by phase microscopy daily 
(100X and 200X).  Bioreactor cells were examined briefly on the first day of culture by 
inverted microscope to determine attachment efficiency and continuation of the experiment 
(40X).  Cells in each bioreactor scaffold were also examined and photographed by phase 
microscopy (40X, 100X, 200X) on the day of harvest for the scaffold.   
 
Evaluation of Functionality 
Cell culture medium was collected daily from each bioreactor reactor-reservoir pair 
and from 3 to 4 wells per culture condition in 2D cultures.  Media samples were centrifuged 
at 14,000 rpm for 4 minutes and supernatants were collected and stored at -20ºC until 
completion of the experiment.  At this time, all samples were thawed at 4ºC and assays 
were performed using a Beckman Coulter DTX880 Multimode Detector plate reader 
(Beckman Coulter, Brea, CA).  Media samples were used to determine production of 
pyruvate and lactate, urea synthesis and albumin production.  Pyruvate and lactate were 
assessed by standard enzymatic procedures (Bermeyer, 1988).  Urea synthesis was 
evaluated using the BioAssay Systems (Hayward, CA) QuantiChrom Urea Assay Kit.  
Albumin production was measured using the Active Motif (Carlsbad, CA) Albumin Blue 
Fluorescent Assay Kit.   Intracellular ATP was measured in some experiments at pre-
determined timepoints.  ATP was measured using the CellTitre-Glo® Luminescent Cell 
Viability Assay (Promega, Madison, WI) according to manufacturer’s protocol and using 
standards made prior to the experiment start and stored at -20ºC.  For RNA analysis, culture 
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medium was removed and replaced with 0.1mL/well TRIzol® (for 2D cultures) or 
0.3mL/scaffold (for 3D cultures) and stored at -80ºC until experiment completion.   
 
Preparation of Treatment Chemicals 
Stock concentrations of both acetaminophen (APAP) and 4-Chloro-6-(2,3-xylidino)-2-
pyrimidinythiol acetic acid (WY-14,643) (purchased from Sigma Aldrich and Chemsyn 
Science Laboratories, Lenexa, Kansas, USA, respectively) were prepared by dissolving the 
compounds in DMSO so as to obtain concentrations 200-fold higher than treatment 
concentrations.  Stock concentrations were stored in aliquots at -80ºC until the day before 
treatment.  On the day before treatment, an aliquot of stock solution was removed and 
thawed to room temperature.  Working solutions for each concentration and day of 
treatment were prepared from this stock aliquot to allow for treatment solutions to have a 
final DMSO content of 0.5%.  These working solutions were stored at 4ºC until day of 
treatment at which time the working solutions were diluted in cell culture medium.    
 
mRNA Isolation and Gene Expression Analysis by RT-PCR 
Cells stored in TRIzol® were removed from culture plate wells or bioreactor scaffolds 
by use of cell scrapers (TPP, Fisher Scientific).   In order to obtain enough RNA from 2D 
cultures, cells from 3-4 wells were combined for evaluation.  Suspensions were placed into 
1.5mL tubes and homogenized using an insulin syringe with 30 gauge needle (BD, Fisher 
Scientific).  The RNA was extracted from the cell lysates by use of the Qiagen RNeasy Mini 
Kit (Qiagen, Valencia, CA) with slight modifications to the original protocol.  Briefly, 
chloroform was added to cell lysates and mixed well.  Lysates were centrifuged at 4ºC for 15 
minutes at 12,000 rpm.  The upper aqueous phase was transferred to a new 1.5mL tube, 
mixed with equal parts EtOH, and transferred to an RNeasy Mini spin column.  The 
remainder of the protocol was according to manufacturer recommendations.  RNA 
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concentrations and quality were measured using a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE).  From these RNA concentrates, 1µg was 
reverse transcribed using a High Capacity cDNA  Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA) according to manufacturer’s protocol.  The resulting cDNA was 
stored at -20ºC until the time of RT-PCR analysis at which point it was thawed at 4ºC prior to 
use.  Real time PCR was performed using the following probes (Applied Biosystems):  
albumin (Mm00802090_m1), Cyp2e1 (Mm00491127_m1), Cyp4a10 (Mm01188913_g1), 
UGT1a1 (Mm02603337_m1), Cyp3a11 (Mm00731567_m1).  The assay was performed in a 
96-well RT-PCR plate (Roche, Indianapolis, IN) and processed using the Roche 
LightCycler® 480 System.  Each plate contained GUSB (a housekeeping gene) as well as 
experimental genes.  The cycle threshold (Ct) for each sample was determined as the time 
when the PCR reaction leaves the exponential phase and enters the final plateau phase.  
The ∆Ct was calculated relative to the control gene (GUSB) as fold change compared to the 
housekeeping gene.   
 
Statistical Data Analysis 
Time-course biochemical assays, gene expression data, and concentration-response 
curves were plotted by GraphPad software (version 4.0, Prism, La Jolla, CA).  Data are 
represented as mean values +/- the standard deviation for at least two replicates per 
condition unless noted otherwise.  Either t-tests or one- or two-way ANOVA was used for 
statistical comparison and a p value of less than 0.05 was determined to indicate statistical 
significance. 
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Figure 1.  Photograph of one multiwell bioreactor system on docking station.  Twelve 
perfused well-pairs (each considered an individual reactor unit).  (a) Full unit with inserts 
of a well-pair with scaffold and a few channels within the scaffold.  (b) The bottom 
pneumatic plate in the docking station, showing built-in connectors and pneumatic lines.  
Size of complete bioreactor system is approximately 127.8 x 85.5 x 34 mm.  Modified 
from Domansky et al., 2010.   Reproduced with permission from Linda Griffith. 
 
PART II:  Bioreactor System Design 
 The 3D multiwell perfused bioreactor system evaluated here was developed by our 
collaborators at MIT, in the laboratory of Linda Griffith (see review of the system in 
Domansky et al., 2010).  The system is composed of a multi-well plate in which isolated 
open-well bioreactors are housed in pairs (a reactor well and a reservoir well) and 
interactions are controlled by a micropump (Figure 1).  Within each reactor well is a scaffold 
containing numerous channels all of which are coated prior to each experiment with an 
extracellular matrix.  The medium is pumped from the reservoir well into the reactor well and 
is reoxygenated by flowing over a shallow surface channel before returning to the reservoir 
well (Domansky et al., 2010).   
The system is composed of two plates – a clear acrylic bottom plate and a yellow 
polysulfone fluidic top plate.  The bottom plate functions as the pneumatic plate; the vacuum 
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Figure 2. Schematic cross-section of a single reactor unit (one well-pair) with all 
components and media flow description.  (1) Direction of maintenance flow (8+ hours 
post seeding). (2) Direction of seeding flow (0-8 hours post seeding). Modified from 
Domansky et al., 2010.  Reproduced with permission from Linda Griffith. 
and air are pumped through small channels in the plate.  The diaphragm pumps built into 
the plate are controlled by an electro-pneumatic controller located outside the incubator.  A 
very thin polyurethane membrane separates the fluidic plate from the pneumatic plate and 
prevents the medium from entering the pumps.  The top fluidic plate has 12 pairs of wells 
which are fluidically isolated from one another.  The top of the fluidic plate is molded to allow 
for a normal 2D multiwell plate lid to fit, thus preventing contamination of the wells.   
The scaffold well of each well pair contains a scaffold placed on top of a hydrophilic 
PVDF filter, polysulfone filter support, and viton O-ring and all are held in place by a 
polypropylene retaining ring (Figure 2).  There is also a PVDF filter in the reservoir well.  The 
scaffold filter is used to trap the cells within the channels of the scaffold immediately upon 
downward flow at seeding.  After the flow is reversed, any unattached cells will be trapped in 
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the reservoir well filter.  During the remainder of the experiment dead cells that detach from 
the scaffold will be trapped on the reservoir well filter as well.   
For each experiment, all components, except the acrylic pneumatic plate, are 
autoclaved (or, for polystyrene scaffolds, sterilized under UV light).  The two plates are 
secured together, by 30 assembly screws and washers, to a pre-specified torque. Each 
bioreactor is then flow tested to make sure the plates are properly secured and that all well 
pairs are functioning properly and within range.  Scaffolds were coated with an extracellular 
matrix and air bubbles were removed from the channels.  All components are loaded into 
the bioreactors; the bioreactors are filled with medium and then placed into the incubator.  
The pumps are set and flow of medium continues for a minimum of 12 hours before medium 
is replaced with fresh medium and cell suspensions are seeded.  Twenty-four hours after 
initial cell seeding, filters in the reservoir wells are removed and replaced.   
 
PART III:  Determining Operating Conditions for the 3D Multiwell Perfused Bioreactor 
 
Evaluation of Changes in Seeding Method 
Cellular attachment to the extracellular matrix is an important factor in functional 
activity in long-term cultures.  Proper attachment leads to re-establishment of cell polarity 
which has been suspected to result in positive cell effects such as increased viability and 
maintenance of proper morphology (Dunn et al., 1989).  For this reason, we examined the 
possibility that the downward flow immediately after seeding could be preventing the cells 
from establishing the necessary orientation and attachment required for proper functionality.   
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Figure 3.  Biochemical analysis of the effect of delaying the start of medium flow on 
pyruvate, lactate, urea, and albumin levels in male C57Bl/6J mouse hepatocytes 
cultured in the 3D multiwell perfused bioreactor.  In normal seeding method medium flow 
was started immediately upon seeding while in the new seeding method medium flow 
was delayed for 2 hours.  Values are the mean ± standard deviation of ≥3 scaffolds.  Day 
of experiment was significant (p<0.05) for both seeding methods and the new seeding 
method was significant (p<0.05) for urea, pyruvate, and lactate levels. 
First we examined how the timing of the downward flow could impact the hepatocyte 
cultures.  We evaluated the start of flow at two timepoints:  seeding cell suspension into the 
multiwell bioreactor and immediately starting downward flow vs seeding cell suspension into 
the multiwell bioreactor and starting downward flow after two hours.  For both multiwell 
bioreactors, as normal, media was changed four hours post seeding.  Flow direction was 
changed to upwards flow 8 hours post seeding for the first bioreactor and 10 hours post 
seeding for the second bioreactor (see Appendix C).  Albumin excretion and urea synthesis 
was evaluated daily.  Two-way ANOVA was used to examine significance of the seeding 
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method and day of experiment.  Figure 3 demonstrates that day of sampling had a 
significant effect on the albumin, urea, lactate, and pyruvate values (p<0.0001).  The new 
seeding method was significantly (p<0.0001) better than the normal seeding in terms of urea 
synthesis, but it did not produce a significant effect on albumin production.  The new 
seeding method was also significant in producing higher lactate (p=0.0034) and lower 
pyruvate (p=0.0017) levels. 
Next, we evaluated a different method of seeding using a more concentrated cell 
suspension (and a lower amount of media – 0.5mL) and leaving the cultures static for 2 
hours before adding more media and starting the downward flow or starting upward flow 
after 2 hours.  These two methods were compared to the normal seeding of adding 1mL cell 
suspension and immediately beginning downward flow (see Appendix C).   Analysis showed 
that day of experiment had a significant effect on lactate, pyruvate, and urea levels for each 
seeding method (p<0.0001; Figure 4).  The seeding method using concentrated cells and 
beginning with an upward flow 2 hours post seeding was significantly higher in terms of 
pyruvate levels (p=0.0387), but not for lactate or urea production (p=0.1728 and 0.3458 
respectively).    
 
Evaluation of Changes in Seeding Density 
The impact cell density has on hepatocyte function has been studied in monolayer 
culture.  Mouse hepatocytes were shown to prefer a lower seeding density of 1.0-1.25 x106 
cells per well than that of human or rat (1.75 x 106 cells per well; using 6 well plates) and 
were more sensitive to high seeding densities (Swift and Brouwer, 2010; Wolf et al., 2008; 
Yue et al., 2009).  The hepatocytes showed an increase in cell death and decreased bile 
canaliculi network formation in high density seeding methods (Swift and Brouwer, 2010).  
For this reason, we examined the effect a lower seeding density may have on hepatocyte 
functionality in the multiwell bioreactor system. 
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Figure 4.  Biochemical analysis of the effect of seeding method on pyruvate, lactate, and 
urea levels in male C57Bl/6J mouse hepatocytes cultured in the 3D multiwell perfused 
bioreactor.  Values are the mean ± standard deviation of ≥3 scaffolds.  Day of experiment 
was significant (p<0.05) for all seeding methods and the concentrated cells with upward 
flow 2 hours post seeding is method was significant (p<0.05) for pyruvate levels. 
Initial experiments evaluating cell seeding density in the multiwell bioreactor systems 
had already been completed prior to my entry into the project.  These previous experiments 
examined seeding densities of 0.25, 0.5, 0.6, 0.8, and 1.0 million cells per reactor well.  
Results (not shown) indicated that 0.6 million cells per reactor well allowed for high 
attachment efficiency and cell viability.  This density was, from that point forward, to be 
considered “normal” seeding density.  One experiment attempted to evaluate cell health with 
a lower seeding density with the hypothesis that the high seeding density may restrict 
available oxygen as well as increase cell death within the tissue formations.  To determine 
the validity of this argument, an experiment comparing two seeding densities (0.3 and 0.6 
million cells per reactor well) was conducted.  By evaluating the urea production and 
albumin secretion per thousand cells, a 2-way ANOVA test showed that both day of 
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Figure 5.  Biochemical analysis of the effect of cell number on urea, albumin, and day 7 
intracellular ATP levels in male C57Bl/6J mouse hepatocytes cultured in the 3D multiwell 
perfused bioreactor.  Values are the mean ± standard deviation of ≥3 scaffolds and 
results are normalized to units per thousand cells.  Day of experiment and seeding 
density were both significant (p<0.05) factors.  
experiment as well as cell density were significant factors (p<0.0001; Figure 5).  The urea 
production was initially higher in the lower seeding density wells, but over time became less 
than that in the higher density wells.  The albumin secretion was much greater at the first 
three days of the experiment for the lower cell density, however by the end of the 
experiment the levels were nearly identical.  ATP on day 7 was examined for each cell 
density.  The seeding density of 300,000 cells per bioreactor well had a lower amount of 
ATP per thousand cells but the difference was not significant (t-test p=0.1286).    
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Evaluation of Flow Rate 
Flow rate of approximately 0.25 mL/min was previously established for rat 
hepatocytes in the multiwell bioreactor system (Domansky et al., 2010).  This rate was 
determined to allow an inlet concentration within the physiologic range of in vivo 
hepatocytes as well as produce a gradient through the tissue by controlling outlet 
concentrations to be almost hypoxic (Domansky et al., 2010).  For rat hepatocytes flow rate 
had been optimized to limit shear stress and provide adequate oxygenation to the cells.  
Flow rates had not been fully evaluated with mouse hepatocytes, thus we examined whether 
the more metabolically active mouse cells required a higher flow rate than that used for the 
rat. 
First, we evaluated three different flow rates (0.2, 0.3, or 0.4 mL/min), using one 
multiwell bioreactor for each flow rate.  In this experiment, day was, again, a significant 
factor in determining the urea synthesis, albumin excretion, and lactate and pyruvate levels 
(p<0.0001; Figure 6).  No significant difference was seen as a result of flow rate in terms of 
pyruvate and lactate production or urea synthesis (two-way ANOVA: pyruvate p=0.3379; 
lactate p=0.0589; urea p=0.6959).  Flow rate was a significant factor in albumin secretion 
(p=0.0243).  The bioreactor wells run at a flow rate of 0.2 mL/min exhibited two single-day 
bursts of increased albumin secretion on days 11 and 15 of the experiment.   
Figure 6.  Biochemical analysis of the effect of flow rate on pyruvate, lactate, urea, and 
albumin levels in male C57Bl/6J mouse hepatocytes cultured in the 3D multiwell perfused 
bioreactor.  Values are the mean ± s.d. of ≥3 scaffolds.  Day of experiment was significant 
(p<0.05) for all flow rates and flow rate of 0.2mL/min was significant (p<0.05) in albumin 
secretion. 
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Figure 7.  Biochemical analysis of the effect of flow rate on pyruvate, lactate, urea, 
albumin, and day 7 intracellular ATP levels in male C57Bl/6J mouse hepatocytes 
cultured in the 3D multiwell perfused bioreactor.  Values are the mean ± s.d. of ≥3 
scaffolds.  Day of experiment was significant (p<0.05) for both flow rates and 0.8mL/min 
was significant (p<0.05) for lactate and albumin levels. 
Secondly, we evaluated the difference between flow rates of 0.4 and 0.8 mL/min.  
Figure 7 shows that day of experiment produced a significant effect in terms of lactate and 
pyruvate production, urea synthesis, and albumin secretion (2-way ANOVA p<0.0001).  
Flow rate had a significant effect on lactate production and albumin secretion (2-way 
ANOVA p<0.0001), although effects were opposite.  Measurements indicated that the higher 
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flow rate consistently resulted in lower lactate and higher albumin levels.  Flow rate was not 
a significant factor for pyruvate production or urea synthesis (p=0.7867 and p=0.1854, 
respectively).  Intracellular ATP production, measured on day 7 of the experiment, showed 
no significant difference between the two flow rates (p=0.8175). 
 
Evaluation of Changes in Scaffold Matrix 
The effects that different extracellular matrices have on hepatocyte cultures has 
been studied and reviewed in depth (Skett, 1994; LeCluyse et al., 1996; Griffith and Swartz, 
2006).  Two matrix configurations have been established which are considered the best 
monolayer culture conditions available at this point in time – single Matrigel® layer and 
sandwich culture (collagen or Matrigel®)( Bader et al., 1992; Dunn et al., 1989; LeCluyse et 
al., 2000; Liu et al., 1999; Dunn et al., 1991).  The matrix used in previous experiments for 
rat hepatocytes in our multiwell bioreactor system, and has shown to support increased urea 
synthesis and albumin production, is a single collagen layer (30µg/mL) (Domansky et al., 
2010).  The scaffolds are soaked in this coating prior to being placed into the bioreactor 
wells.  A single layer of collagen has been shown to be quite inadequate when culturing 
hepatocytes in 2D, however, resulting in poor morphology, and faster decline in P450 
expression (LeCluyse et al., 1996; LeCluyse, 2001; Richert et al., 2002, Meng, 2010; Dunn 
et al., 2989; Bader et al., 1992).  Thus, experiments were performed to determine if a more 
complex matrix would increase hepatocyte functionality as well as increase longevity of 
cultures.  The majority of protocols for coating plates with collagen describe using a collagen 
concentration of 1 to 3mg/mL (Vinken, 2006; LeCluyse et al., 2000; Beken, 1998).  We first 
compared 30µg/mL to 3mg/mL collagen concentrations.  Subsequent experiments also 
compared a 2mg/mL Matrigel® coating.   
In the first experiment, the 3mg/mL collagen appeared to significantly increase the 
amount of urea produced by the cells (even though overall urea levels began much lower 
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Figure 8.  Effect of scaffold collagen concentration on day 7 intracellular ATP levels in 
male C57Bl/6J mouse hepatocytes cultured in the 3D multiwell perfused bioreactor.  
Values are the mean ± s.d. of ≥2 scaffolds.  Higher collagen concentration produced 
significantly higher (p<0.05) day 7 ATP levels. 
than normal and then increased to day 4, opposite normal trends) (data not shown).  Based 
on this, additional wells were added to subsequent experiments to determine if this was a 
repeatable observation.  Urea production was slightly higher again compared to 30µg/mL 
collagen, however albumin excretion did not differ between the two conditions (data not 
shown).  ATP production on day 7 showed a significant difference between the two 
conditions, namely the higher collagen concentration resulted in higher ATP production 
(Figure 8).  When photomicrographs of the wells were examined (Figure 9), however, wells 
containing the higher collagen matrix concentration appeared to have retained a larger 
number of cells which could account for the higher ATP levels (as levels per cell may not be 
different).  Noticeably, all scaffolds had lower than normal number of cells by culture day 7. 
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Figure 9.  Comparison of bioreactor scaffolds on days 1 (above) and 7 (below) of culture.  
The number of cells was much greater on culture day 1 (representative picture for both 
ECM conditions) than on day 7.  On day 7 of culture, scaffolds coated with 30µg/mL 
collagen matrix (left) have less cells than those coated with 3mg/mL collagen matrix (right) 
which may have led to an imprecise assessment of intracellular ATP levels between the two 
ECM conditions.
Fig
ure 10.  Comparison of urea synthesis and day 5 intracellular ATP levels among scaffold 
matrices (30µg/mL collagen, 3mg/mL collagen, and 2mg/mL Matrigel®).  Male C57Bl/6J 
mouse hepatocytes were cultured in the 3D multiwell perfused bioreactor.  Values are the 
mean ± s.d. of ≥3 scaffolds.  Day of experiment was significant (p<0.05) for urea levels of all 
matrix conditions
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Figure 11.  Two separate scaffolds coated with 2mg/mL Matrigel® on culture day 1 (top 
left) and day 5 (top right).  Note that scaffolds have fewer cells on culture day 5.  For the 
duration of the experiment, tissue morphology within the channels of many scaffolds 
coated with 2mg/mL Matrigel® resembled in vivo stucture with cells gathered around a 
central opening that allows for movement of fluid (bottom). 
A repeat of the experiment demonstrated the same trend in urea production.  Another 
experiment compared matrix configurations of 30µg/mL collagen to 3mg/mL collagen and 
2mg/mL Matrigel®.  Urea synthesis and day 5 ATP production did not differ among the 
matrix conditions (Figure 10).   
These results were not expected due to the known benefit of matrigel gel on 2D 
cultures.  Photomicrographs of scaffolds were taken to assess visual morphology as well.  
Again, many scaffolds had lost a majority of cells by day 5 (Figure 11).  Tissue structure 
within scaffold channels coated with 2mg/mL Matrigel® mainly consisted of cells forming a 
ring along channel walls with a central opening for the passage of medium.  This 
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Figure 12.  Effect of scaffold matrix on urea synthesis and day 5 intracellular ATP levels in 
male C57Bl/6J mouse hepatocytes cultured in the 3D multiwell perfused bioreactor.  
Values are the mean ± standard deviation of ≥3 scaffolds.  Day of experiment was 
significant (p<0.05) for urea levels of all matrix conditions.
morphology occurred for the duration of the experiment. 
Combination of experimental results indicated that the Matrigel® scaffold coating 
could have a slightly beneficial function as indicated by ATP values, although urea 
production seemed to remain unchanged (Figure 12).   
  
Evaluation of Mouse Strain 
Two strains were compared to ensure that the lack of increased functionality and 
longevity of the mouse cultures in the 3D bioreactor system was not a strain specific 
phenomenon.  CD-1 mice were compared to the standard C57Bl/6J mice being used for all 
experiments.  Two experiments were performed, and results of biochemical assays of both 
showed no change in albumin secretion, urea synthesis, or ATP production between the 
strains (Figure 13).  Two-way ANOVA showed that day was a significant factor in 
determining urea synthesis, albumin secretion, and ATP production (p= 0.0002, p<0.0001, 
and p=0.0421 respecitvely).  Strain was not a significant factor in any of the three 
biochemical assays. 
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Figure 13.  Biochemical analysis of effect of strain on urea, albumin, and intracellular 
ATP levels in male C57Bl/6J and CD-1 mouse hepatocytes cultured in the 3D multiwell 
perfused bioreactor.  Values are the mean ± s.d. of ≥3 scaffolds.  Day of experiment was 
significant (p<0.05) for both strains. 
 
 
Evaluation of Media Composition 
Media composition has been the topic of numerous publications and general 
formulations for hepatocyte culture have been in use for years.  Soluble factors such as 
serum, pyruvate, proline, glutamine, EGF, insulin, and glucocorticoids have all been shown 
to confer benefit to hepatocyte cultures (Tushcl and Mueller, 2006; Dunn, 1991; Kidambi et 
al., 2009; Klaunig et al., 1981; Tomita et al., 1995; Tamaki, 2005; Talamini, 1998; LeCluyse 
et al., 2000; Dunn, 1989; Laishes, 1976; Yamada 1980; Runge-Morris, 1998).  Non-
physiological chemical substances have also been found to sustain hepatocyte function in 
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culture.  Such substances include nicotinamide, metapyrone, selenium, dimethyl sulfoxide 
(DMSO), and Phenobarbital (LeCluyse, 1996; Nemoto et al., 1995; Rogiers et al., 1990; 
Kost and Michalopoulos, 1991).  DMSO is perhaps one of the best known chemical 
modulators for hepatocyte culture and has been shown to stabilize liver-specific functions in 
hepatocytes, however its method of action is not well understood (LeCluyse et al., 1996; 
Parafita et al., 1983; Kost and Michalopoulos, 1991).  For our purposes, media additions 
were always restricted to physiological substances (a single exception is our normal media 
composition containing selenium) as it is our opinion that chemical additions necessary to 
sustain a functional in vitro system is a poor model for toxicological predictivity. 
 
Evaluation of Media in Two-Dimensional Culture 
Numerous media experiments were primarily performed in two-dimensional 
hepatocyte cultures as the multiwell bioreactor system is limited in the number of culture 
conditions it is able to evaluate at one time (data not shown).  The primary basal medium 
used was Williams E Medium (WEM), however a few other basal media were tried.  In 
addition to the normal supplements, other additions included an amino acid mixture (L-
tryptophan, 0.02mg/mL; L-phenylalanine, 0.1mg/mL; L-methionine, 0.05mg/mL), MEM non-
essential amino acids solution (1% v/v), D-glucose (20mM, 100mM), fructose (1mM, 10mM), 
nicotinamide (10mM), FBS (5%),  lactic acid (0.5, 1.0, 2.0, 4.0, 6.0, 15mM), sodium pyruvate 
(additional 1.0, 2.0, 15mM), EGF (10ng/mL), and ITS (double normal concentration).  
Dulbecco’s Modified Eagle Medium (DMEM) and DMEM-F12 were also tried as basal media 
with the same supplements we normally add to the WEM.  Of the 2D media combinations 
evaluated, only those showing possible positive effects were experimented with in the 
bioreactor system.  These media additions included D-glucose (20mM), fructose (1mM), 
lactate (1mM, 2mM), and MEM non-essential amino acids (1% v/v).  The effects produced 
by substituting basal medium DMEM for WEM were also examined. 
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Figure 14.  Biochemical analysis of the effect of additions of fructose and glucose to 
Williams’ E Medium on pyruvate, lactate, urea, and albumin levels in male C57Bl/6J 
mouse hepatocytes cultured in the 3D multiwell perfused bioreactor.  Values are the 
mean ± s.d. of ≥3 scaffolds.  Day of experiment was significant (p0.05) for all media.  
Differences in media were significant (p0.05) for lactate, urea, and albumin levels. 
Evaluation of Media in Three-Dimensional Culture  
We first examined the addition of D-glucose (20mM) and fructose (1mM) to the 
culture medium.  We found significant differences in biochemical assay results.  Day of 
culture was a significant factor in assay values, as we have demonstrated in the other 
culture conditions (Figure 14).  Media was a significant factor in albumin secretion, urea 
synthesis, and lactate levels (p<0.0001, p=0.0001, and p<0.0001 respectively).  Cells that 
were fed with media supplemented with D-glucose had lower albumin secretion and urea 
synthesis levels throughout the whole culture periods.  Lactate levels in these cells were 
higher as well until day 11, at which point they became lower than the other culture 
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Figure 15.  Biochemical analysis of the effect of additional lactate in culture media on 
pyruvate, lactate, urea, and day 5 intracellular ATP levels in male C57Bl/6J mouse 
hepatocytes cultured in the 3D multiwell perfused bioreactor.  Values are the mean ± 
s.d. of ≥3 scaffolds.  Day of experiment was significant (p0.05) for all media and 
lactate levels were significant (p0.05) among the three conditions. 
conditions.  Pyruvate levels did not vary significantly among the media conditions 
(p=0.9383).  The cells fed with media containing fructose did not vary significantly in 
biochemical analysis from cells fed with regular media except in urea synthesis where levels 
were significantly lower for the majority of the culture period (P=0.0015). 
When we evaluated the addition of lactic acid to the media, no significant difference 
was seen in urea or pyruvate between the cells which received increases of 0mM, 1mM, or 
2mM lactic acid to the media (p=0.1733 and p=0.0937 respectively; Figure 15).  A significant 
difference was seen between the lactate levels in the three conditions (p=0.0234), with 
cultures receiving additional lactic acid producing lower amounts of lactate.  Albumin was 
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Figure 16.  Biochemical analysis of the effect of media and supplements to base media 
on urea and albumin levels in male C57Bl/6J mouse hepatocytes cultured in the 3D 
multiwell perfused bioreactor.  Values are the mean ± s.d. of ≥3 scaffolds.  Day of 
experiment was a significant (p0.05) factor in all biochemical levels. 
not measured in this experiment.  On day 5 of the experiment, ATP measurements varied 
greatly among all the scaffolds but no significant difference was found between the different 
lactate conditions (1-way ANOVA p=0.3837). 
Next, we examined the addition of MEM non-essential amino acids (NMEM) or 
sodium pyruvate (final concentrations of 1% v/v and 20mM respectively) to our basal 
medium as well as the use of Dulbecco’s Modified Eagle Medium (DMEM) as the basal 
medium.  In this experiment, within the multiwell bioreactor system, day was a significant 
factor in both urea synthesis and albumin secretion, however media composition was not a 
significant factor in either biochemical assay (p<0.0001 for day and p=0.0698 for urea and 
p=0.1190 for albumin; Figure 16).  Although the decrease in urea seen in the cells fed with 
the addition of sodium pyruvate to the medium is significant if days 3 and 4 are analyzed 
separately, the overall analysis lacks significance if the values are compared to the WEM 
group (p=0.0520). 
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Discussion and Summary of Optimization and Culture Conditions to Use in Treatment 
and Co-culture Experiments 
 
Three-dimensional culture systems have been under development for years.  Many 
show promise in terms of increasing liver-specific functions and extending culture longevity.  
The multiwell perfused bioreactor system produced in the Griffith laboratory at MIT has 
successfully extended the culture period as well as increasing functionality for rat and 
human hepatocytes (Powers et al., 2002; and Griffith Lab, MIT, unpublished data).  Mouse 
hepatocytes are known to be difficult to culture, often de-differentiating in as little as three 
days of culture when non-physiological factors such as DMSO are not available (Mathijs et 
al., 2009).  We evaluated the effects that changes in bioreactor parameters may have on the 
culture of mouse hepatocytes to establish a set of parameters that would cause the 
hepatocytes to not only increase in functionality but also extend the differentiated state for 
more than a few days.  Pyruvate levels were used as a measure of cellular respiration and 
lactate levels were used as a measure of anaerobic status.  Urea synthesis occurs as a 
result of the metabolism of nitrogen-containing compounds and is unique to the liver thus 
allowing it to be a marker of liver function.  Albumin secretion is another liver-specific 
process which can be used as a marker of synthetic functionality.  Intracellular ATP levels 
are commonly used as a measure of cell viability and general health. These measurements 
were all used to determine the optimal culture conditions for mouse hepatocytes in the 
bioreactor system.    
Day of experiment was consistently a significant factor in the decrease in 
biochemical functionality.  This was expected in two-dimensional culture due to previous 
experiments within our laboratory (Martinez et al., 2010), however it was not expected to be 
as significant in the three-dimensional multiwell bioreactor system.  We had anticipated that 
one, or more, of the changes in operating conditions would decrease the change in liver-
specific functions over time, resulting in a lack of significance of day of experiment.  
49 
 
Experiments conducted examining seeding method and density evaluated the time and 
direction of flow of media as well as a lower seeding density per scaffold.  None of the 
changes resulted in significant increases in cell functionality or culture longevity.  Although 
not statistically significant, intracellular ATP, per thousand cells, was slightly higher in the 
more heavily seeded scaffolds.   
Channels within the scaffolds are individual functional units of the bioreactor system 
and represent a single capillary bed of the liver (Powers et al., 2002).  The important factor 
of media flow in the system then determines the shear stress and oxygen availability for 
each “capillary bed”.  A low flow rate (but not too low of a rate) would keep medium 
concentration within a physiologic range at the bottom of the scaffold and produce an 
oxygen gradient through the tissue.  A flow rate that is too fast will limit the oxygen 
saturation of the media at the air-liquid interface of the surface channel thus decreasing the 
overall oxygen available in the media when it travels to the scaffold well.  The reduction of 
available oxygen will lead to hypoxic conditions for all cells within the system.  This type of 
flow rate will also cause shear stress in cells which has been shown to cause changes in 
cell function and morphology of hepatocytes (Tanaka, 2006).  Flow rates of 0.2-0.4 mL/min 
are targeted to match those found in vivo and shear stress in the system is designed not to 
exceed 30mPa, well within the range found in liver sinusoids (Domansky, 2010; Lalor, 
1999).  Experiments conducted with rat liver cells showed adequate oxygenation of the 
media with flow rates above 0.25 mL/min (Domansky, 2010). Flow rates examined with 
mouse hepatocytes were 0.2, 0.3, 0.4, 0.8 mL/min.  The low flow rate of 0.2mL/min showed 
a statistically significant increase in albumin secretion.  Statistical significance resulted from 
two day-long increases late in the experiment period.  The unexplained phenomenon of two 
isolated days of higher albumin production in the 0.2 mL/min flow rate bioreactor was 
determined to be an aberration as the increase in function was not sustained for more than 
24 hours.  No other biochemical assay showed a significant difference between flow rates 
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and this lack of significant differences was surprising considering the importance of proper 
flow rate in providing the cells with optimal oxygen and shear stress. 
Scaffold matrix experiments indicated, primarily by intracellular ATP results, that the 
low collagen concentration of 30µg/mL may not be the optimal matrix condition for mouse 
hepatocytes in the bioreactor system.  The use of Matrigel® as a scaffold matrix tended to 
produce a slight increase in intracellular ATP levels as well as a cellular conformation that 
was preferable as it more closely mimicked the physiological characteristics of hepatocytes 
and sinusoids. Namely, cells tended to attach to the walls of the channels and leave a 
circular opening in the middle of the channel for media flow.  
Previous work in our lab has shown that strain differences exist in biochemical 
processes, gene expression, and response to chemical treatment (Martinez et al., 2010).  
For this reason, we tested another strain of mouse, CD-1, in the bioreactor system to 
confirm that the C57Bl/6J strain itself was not the cause of rapid de-differentiation.  Mouse 
strain did not seem to affect hepatocyte functionality or longevity of cultures in the bioreactor 
system as indicated by biochemical assays.   
 Media composition does not appear to be a significant factor in how mouse 
hepatocytes perform in the bioreactors.  Media supplementation conferred benefit in certain 
assays, but not others (i.e. adding glucose to the medium caused a decrease in urea and an 
increase in lactate production but did not affect albumin or pyruvate secretion).  We saw a 
trend in increasing ATP with increasing lactic acid concentration in the medium, however 
due to variability between scaffolds the trend was not significant.  Finally, changing the basal 
medium to DMEM did not result in any significant change in biochemical function.   
 Based on the results of all optimization experiments, the culture conditions for 
subsequent experiments were chosen either by using the parameter that gave higher 
functionality or, when no difference was seen, the parameter that correlated with prior 
experiments (ex. Flow rate; Table 1). 
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Seeding Method  (seed and immediately start downward flow, change 
media after 4 hours, change flow direction after 8 
hours) 
Seeding Density  600K per scaffold  
Flow rate  0.4mL/min  
Scaffold ECM  2mg/mL Matrigel®  
Mouse Strain  Varied depending on experiment  
Media Composition  WEM with additions of HEPES, Anti‐Anti, GlutaMAX, 
dexamethasone, ITS (see Appendix A)  
Table 1.  Bioreactor parameters to be used for chemical treatment and co-culture 
experiments.  Parameters were chosen based on optimization of bioreactor parameters 
for mouse hepatocytes. 
 
 
 
PART IV:  Evaluation of Metabolic Capacity of Mouse Hepatocytes in the 3D 
Bioreactor System through Use of Chemical Treatment 
 
Experimental Design 
Normal biochemical analysis revealed that the 3D multiwell perfused bioreactor 
system was not sufficient in itself to enhance the longevity of mouse hepatocyte cultures.  
We determined this through evaluation of urea production, albumin secretion, and ATP 
production.  As in the 2D formats, mouse hepatocytes lost functionality within 3-5 days.  To 
confirm that this loss of functionality extended to loss of metabolic capacity, hepatocyte 
response to treatment was evaluated using two well-known reference compounds:  
acetaminophen (APAP) and 4-Chloro-6-(2,3-xylidino)-2-pyrimidinythiol acetic acid (WY-
14,643).  APAP is metabolized by key cytochrome P450 enzymes and results in cytotoxicity.  
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The use of APAP as a reference compound allows for the evaluation of hepatocyte 
metabolic competence through measurement of expression levels of these cytochromes; 
low expression levels means loss of metabolic capacity and less cytotoxicity.  Treatment 
with WY-14,643 provides evidence regarding the ability of hepatocytes to have metabolism 
induced.  Maintenance of expression levels indicates cells have retained metabolic induction 
capabilities.  The 12 wells of each multiwell bioreactor system were split into two groups – 
the wells of the first group were treated on day 1 and those of the second group were 
treated on day 3 (see Appendix D).  Scaffolds were removed and examined 24 hours post 
treatment for cellular morphological features, intracellular ATP measurements, and RNA 
harvesting.   
 
Evaluation of Hepatocyte Response to Acetaminophen in the 3D Culture System 
First we wanted to confirm that the C57Bl/6J mouse strain would properly represent 
the ability of the bioreactor system to accommodate treatment experiments.  We initially 
performed an experiment using both the C57Bl/6J and CD-1 strains of mice to confirm that 
there was no major difference in metabolic capacity between the two strains (as determined 
through treatment profiles) in the bioreactor system.  We seeded one strain in each of two 
bioreactors and treated half of wells with 7mM APAP on day 1 and the second half of wells 
on day 3.  We examined daily albumin secretion and urea synthesis as well as ATP 
production after treatment.  For both strains of mice there was a decrease in both urea 
synthesis and albumin secretion on day 2 for cells treated with APAP (Figure 17).  On day 4 
there was no difference between non-treated and treated cells in urea and albumin levels.  
Both strains also showed a loss of ATP content after treatment on the first day of culture, 
however this loss was not seen after treatment on day two.  This lack of cellular toxicity later 
in the culture period indicates that the hepatocytes have lost metabolic capacity by day 
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Figure 17.  Urea, albumin, and intracellular ATP levels on days 2 and 4 of culture in 
hepatocytes of two mouse strains after treatment with 7mM APAP.  Hepatocytes were 
isolated from male C57Bl/6J and CD-1 mice. Values are the mean ± s.d. of ≥3 scaffolds.  
No significant change was noted between the two strains.   
three.  These results also demonstrate that loss of metabolic capability was similar in both 
strains, thus we used C57Bl/6J mice for the remainder of treatment experiments. 
Subsequently, dose-dependent relationships and gene expression analysis was 
explored by treating C57Bl/6J mouse hepatocytes in the bioreactor system with APAP and 
WY-14,643.  Two experiments examined the effects of APAP treatment, each performed 
with cells from separate isolations.  Two bioreactors were seeded at the same time with cells 
from a single isolation.  The cells in the first bioreactor were treated with APAP on day 1 and 
harvested for RNA and ATP on day 2.  Two scaffolds were treated with plain media, media 
with 0.5% DMSO (the vehicle for the compounds), or one of four concentrations of APAP 
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(1.0, 3.0, 10.0, 30.0mM).  Upon harvest, one scaffold was used for RNA while the other was 
used to evaluate ATP levels.  The second bioreactor was set up in a similar manner to the 
first, but treatment was not administered until day 3.  Cells were also seeded onto 2D plates 
and treated under the same conditions as controls for cell health, morphology, and 
comparison to previous laboratory data (data not shown).  No concentration dependent 
change was seen in urea production on either of the treatment days.  There was a 
concentration dependent change in albumin secretion for treatment on day 1, but not on day 
3.  A concentration dependent decrease in ATP production was seen for treatment on day 1, 
but not for treatment on day 3 (Figure 18).  The EC50 varied greatly between the two 
treatment days (from 9.603mM to well above 30mM).  The decrease in ATP production 
indicates a loss in cell viability which positively correlates to metabolic functionality. 
The scaffolds removed for RNA analysis showed a slight increase (although not 
significant) in gene expression at high concentrations on day 2 indicating induction of the 
liver specific albumin and Cyp3a11 genes.  On day 4, the levels of Cyp3a11 were virtually 
undetectable, and expression of albumin had decreased drastically. On day 4 there was a 
concentration dependent increase of expression of albumin.  Day was a significant factor in 
determining albumin expression (p<0.0001) as was chemical concentration (p=0.049).   
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Figure 18.  Male C57Bl/6J mouse hepatocytes were treated with varying concentrations 
of acetaminophen on culture days 1 and 3.  Twenty-four hours post treatment, 
intracellular ATP, urea, and albumin levels were measured.  In addition, cells were 
harvested and albumin and Cyp3a11 gene expression was measured. 
 
Evaluation of Hepatocyte Response to WY-14,643 in the 3D Culture System 
Next, the response of mouse hepatocytes cultured in the bioreactor system to treatment with 
WY-14,643 was evaluated.  The set up of the bioreactor systems was the same as that in 
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the APAP experiments; however this experiment was replicated three times.  Variability 
between scaffolds of the same condition was great, however standard deviation of data 
decreased with the addition of each subsequent experiment.   Concentrations of WY-14,643 
were 0.1, 0.3, 1.0, 3.0mM.   
Figure 21 shows that day was not a significant factor in determining treatment related 
responses in relation to urea synthesis, however the concentration response was evident 
(p=0.0258). Neither day nor treatment concentration was a significant factor in determining 
albumin secretion levels.  There was virtually no difference between concentrations on day 3 
treatment. 
Both day 1 and day 3 treatment resulted in a significant concentration dependent 
ATP decrease (p=0.0359), however there was not much change between the EC50 for day 1 
and day 3 (1.981mM and 2.635mM respectively). 
Both day and concentration were significant factors in Acox1 expression (p=0.0234 
for day and p=0.0584 for concentration; Figure 19).  Gene expression analysis showed a 
decrease in expression at the high treatment concentrations on day 2, due to cell toxicity. 
The expression on day 4 is not as variable among the concentrations.  Gene expression for 
Cyp4a10 was significantly affected by day of treatment (p=0.0157), as is evident by the 
drastic decrease in expression at all concentrations from day 2 to day 4.  On day 2, gene 
expression increased with increased treatment concentration except at the highest two 
concentrations and on day 4 all levels were low.  Due to large variability between 
experiments the difference in expression was not significant (p=0.0537). 
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Figure 19.  Mouse hepatocytes were treated with varying concentrations of WY-14,643 
on culture days 1 and 3.  Twenty-four hours post treatment, intracellular ATP, urea, and 
albumin levels were measured.  In addition, cells were harvested and Acox1 and 
Cyp4a10 gene expression was measured. 
 
 
 
58 
 
Discussion of the Evaluation of the Bioreactor System through Use of Chemical 
Treatment 
 
 In our hepatotoxicity experiments, hepatocytes were isolated and allowed to adapt to 
the culture environment for either a 24 or 72 hour period.  An adaptation period has been 
reported to be important in the evaluation of hepatotoxicity in culture systems as it allows the 
cells to adjust to and stabilize within their new environment (Mathijs et al., 2009).  The two 
different periods of treatment afford us the ability to examine the effect of culture time on 
hepatocyte response to treatment.  Four concentrations of each chemical were used as 
treatment as well as vehicle and non-treated groups in each experiment.  Basic biochemical 
functions of urea synthesis and albumin secretion were examined in relation to treatment 
concentrations as was intracellular ATP production and gene expression. 
Treatment with APAP resulted in an inverse relationship between concentration and 
intracellular ATP on day 2.  As ATP content directly correlates to cell viability, and thus 
survival, we are able to establish a dose-dependent model of cytotoxicity with APAP 
treatment in the bioreactor system.  On day 4, however, the response is not as well 
developed indicating that metabolic capacity of the cells has decreased (as noted as an 
increase in EC50 value).  The EC50 for the hepatocytes in the bioreactor system was slightly 
lower than that of the corresponding 2D culture (results not shown) confirming our 
biochemical results indicating the bioreactor system can increase functionality for short-term 
culture.  We saw a similar relationship to chemical concentration and albumin secretion on 
day 2 but not on day 4.  This again indicates that metabolic functionality is lost over culture 
period and thus cytotoxicity is not as prevalent later in the culture period.  No concentration-
dependent change was seen in urea production on either day of assessment.  Gene 
expression of both albumin and Cyp3a11 decreased greatly from day 2 to day 4 of culture, 
an occurrence noted previously in other publications (Mathijs et al., 2009).  A slight, and 
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unexplained, increase in gene expression of albumin with increase in treatment 
concentration was seen.   
Treatment with WY-14,643 produced a concentration dependent response in 
intracellular ATP content on both treatment days and the EC50 was similar for both days.  
This indicates that time in culture is not as significant in WY-14,643 toxicity as in APAP 
toxicity.  EC50 was slightly lower in the bioreactor system than in the corresponding 2D 
cultures (data not shown), again indicating that a slight metabolic benefit was conferred by 
the 3D culture system.  WY-14,643 concentration did not significantly affect albumin 
secretion for either culture day, however urea synthesis was concentration dependent.  
Expression of both Acox1 and Cyp4a10 was concentration dependent on day 2 indicating 
induction of these genes by treatment with WY-14,643.  The low levels measured in the 1.0 
and 3.0mM concentrations are due to cell toxicity.  As we see a decrease in gene 
expression from day 2 to day 4 we know that the cells are losing their gene activity levels 
over the culture period even though toxicity to the chemical remains.   
 Thus, we have determined that the bioreactor culture system is not able to extend 
liver-specific gene expression in mouse hepatocytes to longer than 72 hours.   
 
PART V: Evaluation of Biochemical Function and Metabolic Capacity of Co-cultures in 
the Bioreactor System 
 
Experimental Design 
Co-cultures of hepatocytes with other cell types have been the subject of 
investigation for decades.  Numerous cell types from many different areas of the body have 
been cultured with hepatocytes including fibroblasts (Langenbach, 1979; Michalopoulos et 
al., 1979), endothelial cells (Morin and Normand, 1986; Kim and Rajagopalan, 2010), and 
cell lines (Mendoza-Figueroa. 1988; Donato, et al., 1990; Talbot, 1994). Researchers have 
even used cells from a different species than that of their hepatocytes (Jongen, 1987; 
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Donato et al. 1991; Goulet et al., 1988; Griffith, 1997).  These co-cultures have shown to 
increase and maintain liver-specific functions in hepatocytes.  The focus in our lab, however, 
is on maintaining a similar culture environment to that of the liver in vivo.  To do so, we 
examined cultures of liver non-parenchymal cells (NPCs) and hepatocytes.  
 Our initial experiment used cell preparations containing Kupffer, stellate, and 
sinusoidal endothelial cells.  Two separate isolations were performed to obtain the 
hepatocyte and NP cell suspensions.  The hepatocytes were isolated and seeded into the 
bioreactor system prior to the isolation of the non-parenchymal cells. The NPCs were 
seeded approximately 2 hours after the hepatocytes were placed in the multiwell bioreactors 
(see Appendix E for the flow diagram).  The number of hepatocytes seeded into each 
scaffold was decreased to 450,000 cells so as to not overload the scaffolds with cells and to 
allow for comparisons between conditions.  Wells of hepatocytes alone contained 450,000 
cells; wells containing hepatocytes and NPCs were seeded with 450,000 hepatocytes and 
either 49,500, 193,500, or 450,000 NPCs (equaling ratios of 10:0, 9:1, 7:3, and 1:1 
hepatocytes to NPCs). 
 
Biochemical Analysis and Chemical Treatment of Co-cultures in the 3D System 
Flow cytometry revealed the non-parenchymal cell populations to consist of, on 
average, 32% endothelial cells, 37% Kupffer cells, and 69% stellate cells (although the 
actual stellate percentage was most likely much lower, the high percentage due to non-
specific binding of our antibody; Table 2).  The average yield of NPCs per isolation was 11.4 
million.  Data is expressed as the mean and standard deviation of the three experiments, 
each experiment using two or more scaffolds per condition.  No difference in hepatocyte 
urea or albumin production was demonstrated with the addition of non-parenchymal cells 
(p=0.0684 and p=0.9184 respectively; Figure 20). 
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Experiment  
#  
 
Total cells 
(visual 
count)  
% cells of 
flow count 
that are 
usable ‐NPCs 
CD31 
(endothelial 
cells) 
F4/80 
(Kupffer 
cells)  
GFAP 
(stellate cells) 
1   18 million   22%   41%   32%   44%  
2   13 million   12%   26%   41%   94%  
3   3.3 million   No cells available for flow analysis  
Table 2.  Non-parenchymal cell isolation flow cytometry results. 
Figure 20.  Mouse liver non-parenchymal cells were seeded with hepatocytes in ratios of 
10:0, 9:1, 7:3, and 1:1 hepatocytes:NPCs.  Media was sampled daily and urea and 
albumin levels were measured.   
As demonstrated, mouse hepatocytes within the multiwell bioreactor system lose 
metabolic functionality by culture day 3.  This loss of functionality can be measured by the 
lack of cellular toxicity in response to treatment with acetaminophen.  To determine if the 
presence of non-parenchymal cells could extend the metabolic functionality of our 
hepatocytes through culture day 3, we treated our co-cultures with 10mM APAP.   Cells 
were treated with 10mM APAP on day 3 of culture by methods used in previous hepatocyte 
culture experiments.  Intracellular ATP was measured 24 hours post treatment, on culture 
day 4.   The addition of the other liver cell types did not result in maintenance of enzyme 
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Figure 21.  Mouse liver non-parenchymal cells were seeded with hepatocytes in ratios of 
10:0, 9:1, 7:3, and 1:1 hepatocytes:NPCs.  Cells were treated with 10mM APAP on 
culture day 3 and intracellular ATP levels were measured 24 hours post treatment. 
function; there was no decrease in cell viability after treatment (Figure 21).  The increase in 
viability seen in all treatment groups (although not significant in most groups) is unexplained. 
 
Discussion of Co-culture Experiments 
Many different cell types have been cultured in conjunction with hepatocytes and 
were found to enhance functionality and lengthen culture period.  Previous research has 
indicated that hepatocytes, when cultured with other liver cells, maintain higher levels of 
phase I and II metabolizing enzymes (Rogiers et al., 1990; Conner et al., 1990; Rogiers and 
Vererusse, 1993), are able to maintain levels or slow the rapid decline of albumin secretion 
(Guguen-Guillouzo, 1983; Mesnil, 1987), have an increased tolerance to oxidative stress 
(Mertens et al., 1993), and maintain other liver-specific functions. 
 Our experiments indicate that the addition of Kupffer, stellate, and sinusoidal 
endothelial cells to hepatocyte cultures do not increase or maintain liver-specific functions 
such as albumin secretion and urea synthesis in the multiwell bioreactor system.  There is a 
drastic decrease in both liver-specific functions within the first three days of culture.   Neither 
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does the addition of non-parenchymal cells to the culture system result in a maintenance or 
induction of metabolizing enzymes.  After treatment on the third day of culture there is no 
decrease in ATP, thus no loss of cell viability, indicating a lack of metabolic capacity of the 
hepatocytes.   
Results of numerous experiments demonstrate co-cultures increase hepatocyte 
functionality and viability, therefore we expected to see an increase in at least one of our 
measured parameters (urea synthesis, albumin secretion, or metabolic capacity).  Although 
we cannot positively identify the cause of our negative results, we attribute our results to 
crude non-parenchymal cell suspensions, variable cell quantities, and sub-optimal culture 
conditions.  Our non-parenchymal cell isolation procedure leaves us with a suspension of 
non-parenchymal cells, red blood cells, and cell debris.  Although the debris and red blood 
cells should not hinder attachment of our NPCs to our scaffolds or hepatocytes, we cannot 
fully discern the impact such a crude preparation may have on our cultures.  Our flow 
cytometry data indicate that our cell population in this final suspension consists of a large 
number of stellate cells.  Since the liver is comprised of only 15% stellate cells (van Berkel, 
1979) and recovery of these cells through isolation procedures commonly yields only 10% of 
the population (Alpini et al., 1994), we expected stellate cells to comprise less than 5% of 
our NPC population.  We attribute the high percentage of stellate cells to non-specific 
binding by our antibody, GFAP; we saw a significant decrease in number of stellate cells 
when we titrated the antibody (data not shown).  Therefore, we cannot give a precise 
account of the cell distribution within our NPC preparations and we must question our flow 
cytometry results.  Elimination of the majority of events measured as stellate cells from our 
flow cytometry analysis leaves a substantial number of events which compose the NPC 
population but are not positive for any antibody, leaving us with an “unknown” population of 
non-parenchymal cells.  
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 After we concluded our experiments we determined that our culture conditions were 
not optimal for the survival of the different non-parenchymal cells.  For example, 
investigators have demonstrated that sinusoidal endothelial cells require serum to maintain 
viability; vascular endothelial cell growth factor (VEGF) and other paracrine factors influence 
survival as well (Braet et al., 1994; Krause et al., 2000; DeLeve et al., 2004).  Although 
experiments have shown that in a three-dimensional system with flow co-cultures of 
hepatocytes with SECs can result in survival of the endothelial cells without the use of 
serum and VEGF (Hwa et al., 2007), this has not been established with mouse liver cells.  
Perhaps mouse SECs require the use of serum or VEGF even in the presence of 
hepatocytes and other non-parenchymal cells.  Our results indicated that co-cultures of 
mouse liver cells are not beneficial to the hepatocytes, however due to the many variables in 
our non-parenchymal cell cultures we cannot conclude this with certainty and further 
experimentation is required. 
 
 
 
 
 
 
 
CHAPTER 4 
 
Discussion, Limitations, and Future Directions 
 
Discussion 
 A significant effort has been made in the last few years by research and regulatory 
agencies, such as the NTP and NRC, to promote the use of in vitro assays and decrease 
the use of in vivo work.  In vitro liver models are valuable in drug and chemical safety testing 
as well as for mechanistic research.  A variety of in vitro liver models exist; liver tissue slices, 
microsomes, isolated perfused livers, immortalized hepatic cell lines, and suspensions and 
cultures of primary hepatocytes.  Cultures of primary hepatocytes have been considered the 
best of these options, however long-term culture of fully functioning cells has been difficult to 
obtain.  For this reason, much effort has been spent throughout the years defining optimal 
culture conditions and new culture systems for hepatocytes.   
It has been difficult to develop functional hepatic tissue in vitro and much time has 
been spent over the last two decades attempting to engineer a proper system which would 
recreate the microenvironment of the liver, allow tissue formation similar to that of in vivo, 
retain liver-specific functionality, and maintain cellular viability.  In an ideal system the cells 
would mimic physiological states and may include different cell types, allowing for 
experimentation in liver tissue replacement or toxicological and pharmacological studies. 
Our multiwell bioreactor system incorporates specialized scaffolding, which allows for 
three-dimensional tissue constructs, and dynamic flow of medium to establish a 
physiologically relevant culture model that can be used for study of hepatic pathophysiology 
and chemical toxicity evaluation (Powers et al., 2001).  The system improved functionality of 
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rat and human liver cells as well as extending the life of the cultures (Domansky et al., 2010; 
Griffith laboratory, MIT, unpublished data).  Our goal was to optimize this system for mouse 
hepatocytes for use as multi-strain toxicogenetic models of hepatotoxicity.  Our 
experimentation determined that this system could, in fact, increase functionality of mouse 
hepatocytes for an initial period of three to five days, however functionality could not be 
maintained over long-term culture.   
In order to determine the optimal culture conditions for mouse hepatocytes within the 
bioreactor system, we examined basic parameters such as seeding method, seeding 
density, flow rate, scaffold extracellular matrix, and media composition and their effect on 
biochemical functions in the hepatocytes.  Most of these parameters have been studied 
extensively in traditional two dimensional hepatocyte culture, although not often using 
mouse cells.  Minor differences in initial functionality were seen for some of the parameters, 
however long-term differences were not significant.  None of the changes in parameters 
could stop or even slow the process of murine hepatocyte de-differentiation that typically 
occurs after three to five days in culture.  Minimal experimentation was performed combining 
changes in more than one parameter; however even data from those experiments did not 
show significant differences in cell functionality or culture longevity (data not shown).   
As evident in previous experiments (Martinez et al., 2010), time in culture is a 
significant factor in biochemical functionality of hepatocytes.  Over the culture period, cells 
cannot maintain stable lactate and pyruvate production and they lose their ability to secrete 
albumin and synthesize urea.  This downward trend in functionality was consistent 
throughout all optimization experiments.  Reproducibility between experiments, in terms of 
albumin and urea secretion and synthesis rates, was high indicating that the cell isolations 
and cultures continue to be reproducible processes in our laboratory.  Loss of cell 
functionality after day 3 of experiment is consistent with other published results examining 
two-dimensional mouse hepatocyte culture indicating that our culture system was at least as 
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effective as the traditional culture system in terms of maintaining liver-specific functions over 
time (Nemoto et al., 1989; Nemoto et al., 1991;  Klaunig et al., 1981). 
Although biochemically the bioreactor system did not seem to provide a significantly 
better culture system in terms of longevity, gene expression and chemical treatment were 
evaluated to determine if the system would benefit the mouse hepatocytes in these ways.  
Using the optimal (or, if differences were minimal, the easiest culture method) conditions for 
mouse hepatocytes in the multiwell bioreactor system, cells were treated with both 
acetaminophen and WY-14,643 and cellular response to these treatments was examined.   
 Concentration-dependent cytotoxicity (measured by intracellular ATP content) 
occurred with both chemicals on culture day 2.  On day 4, however, only treatment with WY-
14,643 resulted in a similar cytotoxicity profile.  Cytotoxicity to APAP occurs as a result of 
metabolism of the compound into a reactive metabolite, NAPQI, by cytochromes 1a2, 2e1, 
and isoforms of cytochrome 3a (Zhang et al., 2002; James et al., 2003).  Therefore, the lack 
of cytotoxicity on day 4 indicates a loss of metabolic capacity by said cytochromes.  
Cytotoxicity to treatment with WY-14,643 occurs as a result of the binding of the compound 
to nuclear receptor PPARα leading to its translocation into the nucleus whereupon it acts as 
a transcription factor for genes involved in fatty acid catabolism (Ioannides, 2008).  This 
leads to the formation of peroxisomes within the cytoplasm of the hepatocytes and can lead 
to cellular toxicity.  The maintenance of similar toxicity on day 4 of the experiment for WY-
14, 643 indicates that cells have not lost the ability to have certain metabolic conditions 
induced.  Gene expression analysis for both treatment experiments produced results 
indicative of loss of gene expression and inducibility of said expression over time in culture.  
Curiously, for both treatments, EC50 values of the corresponding 2D cultures did not 
correlate well with that of previous experiments performed within this laboratory (Martinez et 
al., 2010).  One can only speculate as to the reason for the increase in EC50 in these 
experiments when compared to those past; however differences in the location and 
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personnel performing the liver perfusions and cell isolations could account for the lack of 
correlation. The increased seeding density used in the most recent experiments may have 
also had an effect on metabolism. 
We expected that the presence of non-parenchymal cells in our culture system would 
increase hepatocyte functionality.  Unfortunately, we did not find an increase in biochemical 
or metabolic functionality and metabolism capabilities were not extended through the third 
day of culture.  In retrospect, our co-cultures of parenchymal and non-parenchymal liver 
cells were not characterized fully and culture conditions were suspect.  Further optimization 
of isolation procedure, flow cytometry analysis, and culture conditions needs to be 
conducted before we can conclude that mouse hepatocytes are truly unresponsive to the 
presence of other liver cells.   
As reported previously by other authors, expression of key liver-specific and 
metabolic genes and functions could be retained by mouse hepatocytes for up to three days 
in culture (Martinez et al., 2010; Mathijs et al., 2009; Tamaki et al., 2005; Nemoto et al., 
1991; Nemoto et al., 1989).  We were able to show those same results in our experiments 
with the multiwell perfused bioreactor, however we unexpectedly found that the 3D system 
could not maintain expression over a longer culture period than the traditional 2D cultures.  
Although not entirely successful, our research is important to understanding the differences 
between rat and mouse hepatocytes as well as the unique requirements of mouse liver cells 
for successful in vitro culture.  In addition, we have demonstrated that the multiwell perfused 
bioreactor system has a positive effect on mouse hepatocyte culture and continued 
experimentation is required to improve the system and tailor its design to the specific needs 
of this distinctive cell type.  
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Limitations 
 Although the multiwell perfused bioreactor system is a favorable culture system for 
rat and human hepatocytes, it is not ideal for mouse hepatocytes.  The rapid de-
differentiation and loss of hepatocyte function results in a culture system that affords only a 
few days of use.  
 Although extendinging longevity of mouse hepatocyte culture is one of our ultimate 
goals, the system has limitations that need to be addressed if the system is to replace 
traditional two-dimensional culture.  One limitation is the variability between scaffolds.  The 
fact that each scaffold is an independent culture system with its own flow and medium can 
be advantageous in that it allows different conditions to be examined within a single 
bioreactor; however the independence of each well is also a drawback as the variability 
between scaffolds undergoing the same culture conditions is great.  We have shown how 
attachment can vary greatly between scaffolds.  A large number of scaffolds is needed to 
reduce standard deviation which hinders the ability of this system to evaluate multiple 
culture conditions.  The multiwell bioreactor system is also limited by the complex nature of 
the system.  When multiple culture conditions are evaluated a greater number of scaffolds is 
needed to accommodate each assay and each timepoint.  The amount of space, reagents, 
and cells required for each experiment is much greater than in the traditional 2D culture 
system.  Consequently, if the system is not able to maintain higher levels or stabilize the 
liver-specific functions of mouse hepatocytes for long-term culture, then the effort and 
materials required make the perfused multiwell system an inefficient culture method.   
   Although cultures containing non-parenchymal cells have demonstrated benefits to 
hepatocyte function (Ries, 2000; Novik, 2010), our results did not corroborate this.  Further 
research into specific factors needed for the survival of co-cultures indicates that our culture 
medium lacked components that have been shown to be instrumental in NPC survival.  Our 
medium composition may have selectively inhibited certain cell populations within our 
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cultures making our co-cultures inaccurately defined.  Isolation of the NPCs resulted in very 
impure cell preparations that contained a large amount of cell debris and red blood cells.  In 
the future, elutriation or different perfusion methods should be employed to obtain pure 
preparations.  A more pure preparation would allow for more consistent non-parenchymal 
cell yields and cell populations.  The inability to visualize our co-cultures in the bioreactor 
system hindered our ability to properly assess our cultures.  In the future, use of a 
specialized microscope would allow for immunostaining and imaging of cells within the 
scaffolds.  This would be a valuable tool in assessing the number and distribution of NPCs 
within the culture system.   
 Although as currently designed, the multiwell perfused bioreactor system appears to 
be a complicated system which does not afford much use for mouse hepatocyte culture. 
Slight modifications to the system or the use of more specific cultures of non-parenchymal 
cells and hepatocytes could lead to production of a valuable model for liver physiology. 
 
Future Directions 
The paradigm shift from in vivo to in vitro toxicological studies necessitates the 
availability of predictive models, of which hepatocyte culture appears to be a viable option.  
The rapid de-differentiation and subsequent loss of liver-specific functionality severely limits 
the utility of a mouse hepatocyte culture system.  The theory that the long-term cultivation of 
mouse hepatocytes without use of exogenous substances is an unattainable goal is 
incongruous with the evidence that conditions exist that support the maintenance of rat and 
human hepatocytes for long culture periods.  The small amount of research performed using 
mouse hepatocytes, most likely due in part to the small number of cells obtained from each 
animal, is a contributing factor to our lack of knowledge about optimal culture conditions for 
this species.  A concerted effort must be made by a number of researchers to optimize 
culture conditions for mouse hepatocytes.  In doing so, perfusion, isolation, and culture 
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methods can be standardized making experimental results from laboratories all over the 
world more comparable.   
Continued research in the areas of 3D models and co-cultures is imperative to 
develop a model that is able to recreate the liver microenvironment and provide predictive 
results for toxicological and pharmacological studies.  In the near future, our lab will 
investigate a new multiwell perfused bioreactor system and cultures using patterned 
hydrogels.  The new bioreactor system modifies the channel length of the current system 
which will directly affect dynamics between oxygen mass transfer and consumption within 
the system.  The PEG-fibrinogen hydrogels aim to reduce global cell density and improve 
the extracellular matrix environment that plays an important role in hepatocyte culture.  
Ideally, the hydrogels will then be used in the bioreactor system to provide the flow 
dynamics which have been shown to increase and maintain performance of rat and human 
hepatocytes.  An improved ECM and increased oxygen availability in the multiwell perfused 
system may provide an environment more conducive to mouse hepatocyte long-term 
culture.      
A multi-strain mouse model of hepatocytes that can retain functionality long-term 
would be a monumental achievement and has the potential to eliminate the need for much 
of the current in vivo toxicology testing.  Additionally, the availability of a model which can 
mimic the range of responses to a compound in the human population is desperately 
needed.  Research in our lab has provided evidence to suggest that this type of model is 
capable of supplying valuable and relevant toxicity information.  Not only is interindividual 
variation within mouse strains a viable option for examining human drug metabolism, but the 
rise in humanized mouse lines allows for improved risk assessment.  The humanized mouse 
can be used in the cases where there are species differences in response to xenobiotics 
such as differences in P450 expression and nuclear receptor ligand binding affinities seen, 
among others, with human CYP3a4 and rodent CYP3a (Cheung and Gonzalez, 2008).   
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In conclusion, future experimentation in our laboratory with improved co-culture 
conditions, a new multiwell perfused bioreactor system, and an improved extracellular matrix 
will be important in identifying the requirements of mouse hepatocytes in culture and may 
lead to a useful model for toxicological and pharmacological research. 
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APPENDIX A 
Media Formulation 
 
Base Medium was Williams’ E Medium (Sigma W1878).  Supplements below were added to 
each 500mL of base medium. 
 
Chemical 
name 
Amount 
to add 
Final 
concentration 
Stock 
concentration 
Order 
information 
HEPES 5mL 10mM 1M Fisher Scientific 
GlutaMAX™ 5mL 2mM 200mM Gibco   35050-
061 
Dexamethasone 0.4mL 0.1µM 125µM Sigma   D8893 
Insulin-
Transferrin-
Sodium Selenite 
5mL 1.72µM                    
69µM                       
0.1µM                      
0.2mM                      
6.9mM                      
8.5µM 
Gibco   41400-
045 
Antibiotic-
Antimycotic 
(penicillin, 
streptomycin, 
amphotericin B) 
5mL 100 units/mL           
100µg/mL                
0.25µg/mL 
10,000units/mL         
10,000µg/mL           
25µg/mL 
Gibco   15240-
062 
 
Table S1.  Supplements added to each 500mL of Williams’ E Medium.   
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APPENDIX B 
GBS Formulation 
 
The additives below were added to 1L of purified water to make a 10X stock solution of GBS 
(Formulations courtesy of Dr. Lori DeLeve, USC, Los Angeles).   
Chemical name Amount to add Order information 
Potassium chloride  (KCl) 3.7g Acros Organics     
196770010 
Potassium phosphate 
monobasic (KH2PO4) 
0.3g Sigma    
P5655 
Magnesium chloride  
(MgCl2·6H2O) 
2.1g Fisher Biotech     
BP214 
Magnesium sulfate  (MgSO4) 0.3425g Fisher Biotech    
BP213 
Sodium phosphate dibasic         
(NaHPO4) 
1.1975g Fisher Biotech      
BP332 
Glucose 10g Sigma                              
G-7021 
Sodium chloride     (NaCl) 70g Mallinckrodt Chemicals   
7581-06 
Calcium chloride    
(CaCl2·H2O) 
(only for calcium containing 
GBS) 
2.25g Sigma                   
C3881 
Table S2.  Formulation for 1L of 10X GBS solution. 
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To make a 1X solution, sodium bicarbonate was added to 10X stock GBS (with or without 
calcium) and brought up to 1L with purified water. 
Sodium 
bicarbonate     
(NaHCO3) 
2.27g Mallinckrodt Chemicals     
7412 
10X GBS 100mL  
Table S3.  Formulation for 1L of 1X GBS solution. 
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0-0.1 
hours
4 
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0.1 
hours
8 
hours
Seed 1mL cell 
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cells/mL)
Start downward flow Change media Change flow 
direction
BIOREACTOR -
NORMAL SEEDING
BIOREACTOR -
DELAYED FLOW 
SEEDING A
Figure S1.  Illustrations and day 1 time scheme for two methods used to evaluate changes 
in seeding method for male C57Bl/6J mouse hepatocytes in the multiwell perfused 
bioreactor. 
APPENDIX C 
Seeding Methods Layouts 
Illustrations and culture day 1 schemes for seeding method experiments. 
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Figure S2.  Illustrations and day 1 schemes for two additional methods used to evaluate 
changes in seeding method for male C57Bl/6J mouse hepatocytes in the multiwell perfused 
bioreactor. 
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Figure S3.  Illustrations depicting the experimental design for experiments evaluating the 
hepatocyte response to acetaminophen or WY-14,643.  Hepatocytes were isolated from 
male C57Bl/6J mice and seeded into two 3D multiwell perfused bioreactor systems.  Cells in 
the bioreactors were treated with chemical on days 1 and 3 and harvested 24 hours post 
treatment for intracellular ATP and RNA measurements.  This illustration contains the 
concentrations used in APAP experiments – C (control, 0mM), V (vehicle, 0.5% DMSO), 
and 1.0, 3.0, 10, and 30mM. 
APPENDIX D 
Treatment Experiments - Layout 
 
Illustrations of the experimental design and culture scheme for mouse hepatocytes in 2D 
culture and the 3D multiwell perfused bioreactor system. 
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Figure S4.  Schematic diagram depicting culture days 0-5 of experiments evaluating 
hepatocyte response to treatment with either APAP or WY-14,643.  Cells were isolated from 
male C57Bl/6J mice and seeded onto 2D plates or 3D multiwell bioreactor systems (day 0).   
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Purified Hepatocytes
Purified Non-parenchymal Cells
0-1 hours
1-3 hours
 
Figure S5.  Illustration of isolation and seeding time periods of hepatocyte-non-
parenchymal cell co-cultures.  Hepatocytes were isolated from male C57Bl/6J mice, cell 
suspensions were purified, and cells were seeded into each well of bioreactor systems in 
hours 0-1 of culture day 0.  Within hours 1-3 of culture day 0, non-parenchymal cells were 
isolated from male C57Bl/6J mice, cell suspensions were purified, and cells were seeded 
into half of wells previously seeded with hepatocytes.  Cells were seeded into ratios of 10:0, 
9:1, 7:3, and 1:1 hepatocytes:NPCs. 
APPENDIX E 
Co-culture Experiments - Layout 
Illustrations of the isolation and culture schemes for hepatocyte-non-parenchymal co-
cultures. 
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Day 0
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Day 1 Day 2 Day 3 Day 4 Day 5
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•Harvest 
remaining 
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Figure S6.  Schematic diagram of culture days 0-5 of experiments evaluating biochemical 
function and metabolic capacity of co-cultures in the bioreactor system.  Hepatocytes and 
NPCs were isolated from male C57Bl/6J mice and seeded into 2D plates and 3D bioreactor 
systems on culture day 0.   
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